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ABSTRACT 
 
    Amphitropic proteins, such as the virulence factor phosphatidylinositol-specific 
phospholipase C (PI-PLC) from Bacillus thuringiensis, often depend on lipid-specific 
recognition of target membranes. However, the recognition mechanisms for zwitterionic 
lipids such as phosphatidylcholine (PC), which is enriched in the outer leaflet of 
eukaryotic cell membranes, are not well understood. Molecular dynamics (MD) 
simulation and mutagenesis results strongly indicate that PI-PLC interacts with PC head 
groups via cation-π interactions with aromatic tyrosine residues, and suggest that cation-π 
interactions at the interface may be a mechanism for specific lipid recognition by 
amphitropic and membrane proteins. 
    Aromatic amino acids can not only form cation-π interactions at the interface but also 
insert into membranes and have hydrophobic interactions with lipid tails. Heretofore 
there has been no facile way to differentiate these two types of interactions. We show that 
specific incorporation of fluorinated amino acids into proteins can experimentally 
distinguish cation-π interactions from membrane insertion of the aromatic side-chains. 
Fluorinated aromatic amino acids destabilize the cation-π interactions by altering 
electrostatics of the aromatic ring while their enhanced hydrophobicity enhances 
!membrane insertion. Incorporation of pentafluorophenylalanine or difluorotyrosine into a 
Staphylococcus aureus phosphatidylinositol-specific phospholipase C (PI-PLC) variant 
engineered to contain a specific PC-binding site demonstrates the effectiveness of this 
methodology. Applying this methodology to the plethora of tyrosine residues in Bacillus 
thuringiensis PI-PLC identifies those involved in cation-π interactions with PC.  
    Cation-π interactions provide a likely molecular mechanism for BtPI-PLC PC 
specificity but do not account for its preference for bilayers containing a small fraction of 
anionic lipids. MD simulations and fluorescence correlation spectroscopy (FCS) vesicle 
binding measurements of positively charged amino acids as well as surface tyrosine 
residues are used to formulate a complete model of BtPI-PLC specific binding to mixed 
anionic phospholipid/PC membrane. 
    DNF2, a new plant protein with homology to bacterial PI-PLC, is confirmed to be the 
first plant small PI-PLC enzyme that can cleave both PI and glycosylphosphatidylinositol 
(GPI) anchored proteins. GPI-anchored protein cleavage also confirms that DNF2 plays 
an important role in symbiosome, the intracellular compartment formed by the plant that 
contains nitrogen fixing bacteria.  
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Chapter 1 
Introduction 
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1.1 Amphitropic proteins 
    Peripheral membrane proteins refer to those that are water-soluble, and have reversible 
interactions with membrane [1]. They adhere only temporarily to the biological 
membrane either through direct interactions with the polar head group of phospholipid in 
the bilayer or through indirect interactions with an integral membrane protein. 
Amphitropic proteins have both lipophilic and hydrophilic characteristics and bind to 
lipids in the cell or organelle membrane in order to function. 
     Several structural motifs have been employed by amphitropic proteins to associate 
with membranes: lipid clamps, covalent lipid anchors and amphipathic helices. Lipid 
clamps contain motifs that associate specifically with the head groups of lipid monomers 
(Figure 1-1A). These motifs have been found in C1, C2 and PH (pleckstrin homology) 
domains. [2,3,4]. C1 domains bind diacylglycerol (DAG) and phorbol esters; C2 domains 
usually bind calcium, phosphatidylserine or phosphatidylcholine; The PH domains bind 
different phosphoinositides. Another class of amphitropic proteins contain lipid covalent 
anchors which can insert into the membrane (Figure 1-2A). At the cell surface, these 
lipid-anchored proteins can be covalently attached to the lipids 
glycosylphosphatidylinositol (GPI) and cholesterol [5]. Often this is a reversible process, 
as the acyl chain of the protein can be buried in the hydrophobic binding pocket after 
dissociation from the membrane. In addition, many proteins in this category combine a 
single lipid anchor with a polybasic site that interacts electrostatically with the negative 
polar head group region of a membrane. A third class of proteins contains an amphiphatic 
α-helix, which non-specifically binds to a membrane by partitioning into the membrane 
bilayer (Figure 1-3A). The hydrophobic face of the helix is sequestered from water, while 
! 3!
its polar face can still contact the aqueous phase. One example of this class of protein is 
DnaA [6].  
Figure 1-1. Schematic reperesentations of membrane binding motifs of amphitropic proteins. (A) 
lipid clamp; (B) lipid covalent anchors; (C) amphipathic helix; (D) hydrophobic loops. 
 
 
 
 
    Besides these interactions, unstructured hydrophobic loops on the protein surface can 
also contribute to the protein interactions with membrane (Figure 1-1D). Cation-π 
interactions that happen between aromatic residues of protein surface and positive 
charged portions of the phospholipid head groups, also play an important role in lipid 
recognition and interactions. Examples where loops contain key membrane interacting 
residues include cytochrome P450, annexins as well as phospholipases [7]. 
    Amphitropic proteins bind reversibly to lipid vesicles with equilibrium association 
constants typically between 103 M-1 to 107 M-1 [7]. For many of them it is thought that  
electrostatic interactions drive their positioning and orientation at the membrane surface 
thus facilitating the intercalation of a few hydrophobic groups. It is generally 
acknowledged that the association of amphitropic proteins with lipid bilayers is fast while 
the dissociation is slow; the dissociation rate constant is thus the main determinant of the 
binding strength. As a consequence, in simple systems where the protein does not 
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undergo conformational changes and does not interact with other proteins, the affinity for 
the membrane is mostly accounted for by interactions between the protein interfacial 
binding site and lipids. The energy and specificity of these interactions is generally 
estimated by including contributions from electrostatics, −1.4 kcal/mol for each 
positively charged amino acid interacting with the lipid headgroups [8], and hydrophobic 
interactions with the bilayer core, −0.8 kcal/mol per acyl chain CH2 group interacting 
with the protein [9]. Recently we have reported approximately −2.5 kcal/mol for an 
aromatic amino acid binding to positive charged lipid head group [10]. 
1.2 Phospholipids 
    The biological membrane consists mainly of lipids and proteins. There are three major 
types of membrane lipids: steroids, glycolipids, and phospholipids. Phospholipids are the 
most abundant class of membrane, comprising 20-80% of the membrane mass [11,12]. In 
eukaryotic membranes, glycerophospholipids are the major components: 
phosphatidylcholine (PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), 
phosphatidylinositol (PI), phosphatidylglycerol (PG) and phosphatidic acid (PA) (Fig. 1-
2) [12]. Phospholipids are!amphiphatic,!composed of a hydrophilic headgroup (R-) and 
hydrophobic acyl chains.!The different polar head groups linked by the glycerophosphate 
moiety generate phospholipids that are either zwitterionic (PC, PE) or anionic (PI, PS, 
PG, PA) (Fig. 1-2).  
    A phospholipid bilayer is also called bimolecular sheet. The hydrophilic head groups 
interacting with the aqueous medium on each side of the sheet, and hydrophobic tails of 
each individual sheet interact with one another. 
    Besides lipid bilayer, a variety of aggregates can be formed from phospholipids in 
! 5!
aqueous solution mainly through hydrophobic interactions of the acyl chains [13]. As 
shown in Figure 1-3, at the air-water interface, lipids always form monolayers with the 
polar headgroups in the aqueous solution and the acyl chains stick into the air. In aqueous 
solutions, phospholipids are present as monomers as well as different forms of aggregates 
depending on the concentration and length of the acyl chains [14]. Below critical micelle 
concentration (CMC), they exist as monomers.  If acyl chain lengths are short (e.g., 
dihexanoyl-PC, diC6PC) or the polar head groups are very large (e.g., ganglioside GM1) 
the lipid molecules aggregate to form micelles. Phospholipid mixed with a detergent at a 
proper ratio will form detergent mixed micelles. If the acyl chains are moderately long, 
the molecules aggregate and form bilayer vesicles, MLVs (multilamellar vesicles) if just 
hydrated with water, and SUVs (small unilamellar vesicles) and LUVs (large unilamellar 
vesicles) if one extrudes the MLVs through a small orifice or sonicates the MLVs. Both 
SUVs and LUVs are good models to study membrane protein function, folding and 
assembly. SUVs are highly curved with 20–50 nm diameters; these are easily prepared by 
sonication [15]. LUVs can be prepared that have a wide range of sizes, from 50 to 1000 
nm. Both the micelle and vesicle systems are widely used as models to study protein-
membrane interactions and other cell processes that have membrane bound constituents. 
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Figure 1-2. General phospholipid structure. 
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Figure 1-3.  Physical states of phospholipids in aqueous solution. !!
 
 
 
1.3 Phosphatidylinositol-specific phospholipase C (PI-PLC) enzymes 
    Phospholipase enzymes hydrolyze different ester linkages in a variety of phospholipids 
[16]. Phosphatidylinositol-specific phospholipase C (PI-PLC) enzymes are a large family 
of phospholipases that specifically catalyze the hydrolysis of polar head group of 
phosphoinositide substrates. The substrates of bacterial PI-PLC enzymes are PI and 
glycosylphosphatidylinositol (GPI), while most mammalian enzymes prefer PIPn (PI 
molecules phosphorylated on C4 and C5 of the inositol ring), which are important in 
signaling pathways [17,18]. In our lab, a new plant protein DNF2 has been confirmed to 
be able to hydrolyze PI and is a first small plant PI-PLC enzyme resembling a bacterial 
PI-PLC.  
! 8!
 
Figure 1-4. The mechanism of the two sequentially reactions catalyzed by bacterial PI-PLC. 
(adapted from Jiongjia Cheng’s thesis, Boston College, 2013).  !
!!
 As shown in Figure 1-4, the bacterial PI-PLC cleaves its substrate via an intramolecular 
phosphotransferase reaction of the PI moiety to form a cyclic inositol phosphate molecule 
(inositol 1,2-cyclic phosphate, or cIP) and diacylglycerol (DAG) [19]. The enzyme 
further hydrolyzes the water-soluble intermediate cIP to inositol-1-phosphate (I-1-P) 
[20,21].  A similar mechanism is used by mammalian PI-PLCs, except that Ca2+ is used 
to stabilize the transition state. 
     Bacterial PI-PLC is a virulence factor produced and secreted by many Gram-positive 
bacteria, including the pathogens Bacillus cereus, Bacillus thuringiensis, Listeria 
monocytogenes, and Staphylococcus aureus. [22-28]. In addition to the cleavage of non-
phosphorylated PI, PI-PLCs secreted by extracellular pathogens (e.g. Bacillus and 
Staphylococcus strains) can also cleave GPI anchors [22] to release proteins that are 
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tethered to the outer surface of mammalian cell membrane. One of the products, DAG, a 
second messenger, can translocate across the bilayer [29] to interfere with intracellular 
signaling processes [30].  
    The mammalian phospholipase C family has thirteen isozymes: PLC-β(1–4), PLC-γ(1–2), 
PLC-δ(1,3,4), PLC-ε, PLC-ζ, and PLC-η ( Figure 1-5) [31]. These PLC isoforms share four 
EF-hand motifs (usually associated with Ca2+ binding), the X and Y catalytic domains, a 
C-terminal C2 domain for calcium-dependent membrane targeting and a N-terminal PH 
domain (the one exception is PLC-ζ) to localize the enzymes to their substrate in the 
membrane and also to interact with other signaling components [32,33].  
 
Figure1-5. The mammalian PLC family. (adapted from [31]) 
 
 
 
 
    In contrast to their multi-domain eukaryotic relatives, the bacterial PI-PLCs have a 
single catalytic domain (homologous to the X-Y domains of mammalian PLC enzymes) 
for both catalysis and membrane binding.  
    There are two crystal structures of mammalian PI-PLC enzymes, PI-PLC δ1 (Figure 1-
6A) and PI-PLC β2 (Figure 1-6B). Both the catalytic domains adopt a (βα)8-barrel (TIM 
barrel) structure. The structures of PI-PLCs from B. cereus, B. thuringiensis, S. aureus 
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and L. monocytogenes have been solved. They all fold as a single domain and are 
homologous to the catalytic domain in mammalian PI-PLCs. Secondary structures 
superimpose well with each other (Figure 1-6C). Sequence alignment of the three 
bacterial PI-PLCs shows 26−40% identity (Figure 1-7). Two key structural features of the 
bacterial enzymes have been implicated in membrane binding [34-37]. One is short helix 
B (containing Trp47 in Bacillus PI-PLC and Trp45 in S. aureus PI-PLC) and the other a 
mobile rim loop (containing Trp242 in Bacillus PI-PLC and Phe249 in S. aureus PI-
PLC). In S. aureus PI-PLC, helix B is one residue longer than in the B. cereus structure 
and has two positive charged lysine residues. This can form an extended positively 
charged motif when combined with the other positively charged residues in the barrel 
rim. The key hydrophobic residue in the mobile rim loop can adopt different orientations. 
For example, under basic conditions, Phe249 in S. aureus PI-PLC [38] is pointed outward 
and toward the membrane interface compared with the homologous side chain (Trp242) 
in Bacillus enzymes. In the latter the tryptophan residues are pointed away from the 
membrane interface. This stresses the flexibility of the rim loop [38]. In L. 
monocytogenes, Trp 49 in helix B points inward where it may be involved in interacting 
with substrates. F247 in rim loop that is homologous to Trp242 in Bacillus enzymes 
points outward and can insert into the membrane through hydrophobic interactions  [49].  
 
 
 
 
 
 
! 11!
Figure 1-6. Comparison of the overall structures of different PI-PLC enzymes: (A) PLC δ1 
(1QAS); (B) PLC β2 (2FJU); (C) superposition of B. cereus PI-PLC (1PTG), S. aureus PI-PLC 
(3V16) and L. monocytogenes PI-PLC (1AOD). PH domain (green), EF hand (magenta), catalytic 
domain (cyan), C2 domain (yellow). 
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Figure 1-7. Sequence alignment of the three bacterial PI-PLCs. 
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1.4 Interfacial activation and inhibition of PI-PLC  
    ‘Interfacial activation’ is a sharp increase in enzyme activity when the substrate is 
presented at an interface as opposed to a monomer molecule [39] and this effect has been 
observed for many peripheral enzymes, including phospholipases. For hydrolysis 
reactions taking place at an aqueous-lipid interface, the enzyme in the solution must 
initially bind to the interface. The interface-associated enzyme likely undergoes some 
conformational changes to bind the substrate in the active site. When one hydrolysis 
cycle finishes, the enzyme releases the products to regenerate free enzyme and looks for 
the next substrate [40]. The overall rate of the catalytic turnover is thus affected not only 
by the kinetics of those interfacial catalytic steps but also by the kinetics of binding and 
desorption of the enzyme at the interface. B. thuringiensis PI-PLC exhibits a second type 
of ‘interfacial activation’. In the presence of zwitterionic phospholipid PC, a large 
enhancement of the enzyme specific PI-PLC activity is observed. Much of the enhanced 
activity generated by this non-substrate phospholipid is thought to represent a specific 
binding interaction [41].! 
     However, adding more non-substrate lipids dilutes the substrate concentration at the 
interface and this local concentration instead of bulk lipid concentration is important for 
the overall kinetic rate. This phenomenon is called “surface dilution inhibition” [42,43]. 
The bacterial PI-PLCs also exhibit “scooting mode catalysis”, where enzyme completes 
several rounds of substrate catalysis at the substrate interface before dissociating from the 
particle [44]. Scooting mode catalysis becomes extremely important with the decreased 
interfacial substrate concentration. 
    The Bacillus PI-PLC enzymes are activated by strong binding to PC [20,37,47]. Recent 
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work on B. thuringiensis PI-PLC vesicle binding, combining high-resolution field-
cycling 31P NMR relaxation experiments [37] with mutagenesis studies [45] have shown 
that there is a discrete binding site for the activator PC. The specific PC binding site was 
suggested to be rich in tyrosines that could form choline cation/Tyr π boxes or 
sandwiches. It was suggested that a tyrosine strip (Tyr246-248 and Tyr251) near the 
membrane interface forms the PC recognition motif. However, all the evidence for the 
PC binding pocket was indirect and required further experiments to validate this 
hypothesis. Interestingly, a mutant of S. aureus PI-PLC, while the wildtype protein shows 
weak PC affinity, exhibited greatly enhance affinity for PC. The mutant enzyme was 
constructed to mimic the tyrosine strip of B. thuringiensis [46]. A specific PC binding site 
was identified in a crystal structure of the mutant N254Y/H258Y [46]. It suggested that 
the choline cation/ tyrosine π interactions contribute to the PC binding affinity. However, 
the crystal structure used a soluble PC and only the polar headgroup was visible. Further 
work was needed to confirm the importance of those tyrosine residues on BtPI-PLC and 
to clarify if they interact through cation-π interactions.  
     Although it may be important for other amphitropic proteins, PC binding is not a 
universal mechanism of interfacial activation for bacterial PI-PLCs. S. aureus PI-PLC has 
weak affinity for PC and is sensitive to salt. Instead of binding, PC modulates the pH and 
salt dependence of S. aureus PI-PLC activity. The higher the PC content, the less 
sensitive the enzyme is to salt and the higher the specific activity [48]. The enzyme from 
Listeria monocytogenes is activated by many noncharged or zwitterionic amphiphiles in a 
nonspecific fashion [49]. Consistent with this mode of PC activation, L. monocytogenes 
PI-PLC has very low affinity for PC SUVs but very high affinity for anionic phospholipid 
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interfaces. Adding PC reduces the interfacial negative charge which in turn prevents 
aggregation of the protein to form nonproductive complexes [49]. 
1.5 Membrane binding assays for amphitropic proteins 
    Membrane binding is critical for amphitropic proteins to carry out their cellular 
function, a sensitive and quantitative method for measuring membrane affinity is 
essential. 
    Traditional binding methods include assays that involve physical separation of 
membrane bound proteins and free proteins such as centrifugation and gel filtration, or 
indirect assays that allow monitoring of membrane-protein binding, such as fluorescence 
and NMR line-width methods [50]. Centrifugation to separate free and vesicle-bound 
protein is the simplest assay. It is useful for a first estimation of binding affinity. 
However, the major drawback of this kind of assays is that the long centrifugation time 
may perturb the binding equilibrium. Thus the Kd measured may not be the true 
equilibrium constant [51,52]. Chromatographic gel filtration assays are less sensitive and 
require large amounts of both protein and lipids. 
    Fluorescence spectroscopy has been adopted for monitoring protein that contains one 
or more tryptophan (or tyrosine) residues in the vicinity of the membrane binding surface. 
The intrinsic fluorescence of the protein, dominated by tryptophan, is sensitive to the 
changes in polarity of the environment. When protein binds to the hydrophobic core of 
membranes, tryptophan fluorescence generally shifts to a shorter wavelength and exhibits 
an increase in intensity [53-55]. This method requires the presence of tryptophan residues 
at the membrane interface. However, multiple tryptophan residues at the interface might 
cancel each other out. Also, different changes can occur for different lipids and variable 
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sensitivity have greatly limited the application of this method. As an alternative, Förster 
resonance energy transfer (FRET) has been widely used [56-58]. In these experiments, 
fluorophore containing lipids (e.g., dansyl- or pyrene- lipids) are incorporated in the 
membranes; the absorption spectrum of the lipids strongly overlaps with tryptophan 
emission. Thus, association of the protein with the bilayer results in quenching of the 
tryptophan fluorescence due to FRET. Compared to intrinsic fluorescence, this assay has 
a higher sensitivity, yet it still requires the presence of tryptophan in the protein or an 
introduced extrinsic fluorophore whose absorption or emission spectrum overlaps with 
the lipid fluorophore. 
    Fluorescence correlation spectroscopy (FCS) can be used to replace intrinsic 
fluorescence or FRET. It has a much higher sensitivity and lower sample requirement 
(<10 nM protein and µL volumes) [59-61]. Tryptophan residues, which have only 
moderate quantum yields and are easily bleached, are not suitable for nM detection. By 
introducing on the protein an extrinsic fluorophore, the protein and lipid donor/acceptor 
pair can be chosen to optimize quantum yield and stability to bleaching. FCS uses the 
difference in Brownian motion of free and vesicle-bound protein. Vesicle bound protein 
has a retarded translational diffusion speed and this change can be easily measured by 
FCS. Also, the protein concentration used in FCS is comparable to what is used in kinetic 
assays. I have mainly used this assay to study PI-PLC interactions with SUVs composed 
of both zwitterionic and anionic lipids during my thesis work. 
    Surface plasmon resonance (SPR) methods have also been developed to measure 
binding affinity of different interacting species. Binding is monitored by measuring the 
refractive index change caused by the increased mass introduced onto the SPR chip 
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[62,63]. In a typical SPR assay, lipids are immobilized on the sensor chip surface that 
forms a wall of the sample cell and protein solution of different concentrations flows 
through the cell. When protein binds to the membrane, the refractive index near the 
surface will be changed and the signal can be recorded in real time. It is label free and the 
rate constants for association (ka) and dissociation (kd) steps can be extracted in real time. 
However, this assay also has its limitations. Nonspecific binding can complicate the 
interpretation of the binding result. Also, the determined Kd = kd/ka is expressed in terms 
of molarity of protein binding sites instead of lipid concentration. Most importantly, lipid 
immobilization results in a planar surface without curvature, which is a potential problem 
in working with the bacterial PI-PLC enzymes that prefer high curvature for membrane 
binding. 
    Isothermal titration calorimetry has also been developed for characterizing the binding 
affinity of proteins with their ligands. It has high precision and sensitivity to exothermic 
and endothermic heat changes as well as the capacity to simultaneously determine the 
association and dissociation constant, the binding enthalpy and the binding stoichiometry 
[64]. One of the significant drawbacks of this technique is the complexity of data analysis 
for non-standard models. It also requires a large amount of protein, which might be a big 
problem for precious samples.  
1.6 Thesis directions 
    The first aim of my dissertation is to define the overlooked cation-π interactions and 
formulate a complete model to understand the mechanism of BtPI-PLC membrane 
binding. In order to investigate the cation-π interactions, we combined MD simulations, 
mutagenesis along with binding and activity assays, to study the role of tyrosine residues 
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at the protein membrane surface in regulating the binding and activity of BtPI-PLC. 
Tyr86, Tyr88, Tyr204, Tyr246, Tyr247, Tyr248 and Tyr251 were associated with DMPC 
bilayer binding affinity in simulations. This observation in MD simulation led us to 
mutate these tyrosines to alanines. The variations in both enzymatic activity and vesicle 
binding affinity between mutant protein and WT were measured to identify the important 
tyrosine residues in cation-π interactions with membrane.!!!!!
    Aromatic amino acids can not only form cation-π interactions at the interface but also 
insert into membranes and have hydrophobic interactions with lipid tails. Heretofore 
there has been no facile way to differentiate these two types of interactions. To 
experimentally distinguish cation-π interactions from membrane insertion of the aromatic 
side chain, we introduced fluorinated amino acids into proteins. Fluorinated aromatic 
amino acids destabilize the cation-π interactions by altering electrostatics of the aromatic 
ring while their enhanced hydrophobicity enhances membrane insertion. SaPI-PLC was 
used as a model system. Incorporation of pentafluorophenylalanine or difluorotyrosine 
into mutant N254Y/H258Y engineered to contain a specific PC-binding site would 
demonstrate the effectiveness of this methodology. And this methodology would be 
applied to the plethora of tyrosine residues in BtPI-PLC to identify those involved in 
cation-π interactions with PC.  
    Cation-π interactions provide a likely molecular mechanism for BtPI-PLC PC 
specificity but do not account for its preference for bilayers containing a small fraction of 
anionic lipids. MD dynamic simulation and FCS affinity measurement of positive 
charged amino acid as well as surface tyrosine residue mutants, we could formulate a 
complete model of BtPI-PLC specific binding to anionic PC-containing lipid. 
! 19!
    Finally, dnf2, a gene important for plant nitrogen fixation in the nodule organism, has a 
hypothetical homology protein structure to bacterial PI-PLC. To identify if it is a PI-PLC, 
the gene was cloned into tagged vectors and recombinant protein was expressed. The 
crude cell lysate could be subjected to activity assay towards PI to determine if it was a 
PI-PLC. Once confirmed, more assays could be performed using purified DNF2 protein.  
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2.1. Materials 
2.1.1. Molecular biology reagents 
    The pET-23a(+) vector and pET-28a(+) vector were obtained from Novagen. The 
pGEX-6p-1 GST expression vector was purchased from GE Healthcare. Restriction 
enzymes, IMPACT kit (including pTXB1 vector), Taq DNA polymerase, Quick Ligation 
kit, and Antarctic phosphatase were purchased from New England Biolabs. The 
QuikChange site-directed mutagenesis kit, Quikchange Lightening site-directed 
mutagenesis kit, competent cells used for cloning and mutagenesis (XL-1 blue or XL 10-
gold), and overexpression (BL21 (DE3) Codonplus) were purchased from Agilent 
Technologies. The BL21 Star (DE3) One Shot competent cells were purchased from 
Invitrogen. The QIAprep spin miniprep kit, QIAquick PCR purification kit and QIAquick 
Gel Extraction kit were purchased from Qiagen. All the PCR primers were purchased 
from Eurofins MWG Operon.  Pasmids pEVOL-pylT-PylRS and pEVOL-F2YRS were 
obtained from Dr. Wenshe Liu (Texas A&M) and Dr. Jiangyun Wang (Institute of 
Biophysics, Chinese Acadamy of Sciences), respectively.  
2.1.2 Resin for purification 
    The Q Sepharose fast flow resin, phenyl sepharose resin and glutathione sepharose 4B 
resin were purchased from GE Healthcare. Micro bio-spin 6 columns and AG50W-X8 
resin were purchased from Bio-Rad Laboratories. Ni-NTA agarose resin was purchased 
from Qiagen. Chitin resin was purchased from New England Biolabs.    
2.1.3 Phospholipids 
    Most of the lipids used in this work were purchased from Avanti Polar Lipids Inc., and 
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used without further purification. These include the long chain lipids 1-palmitoyl-2-
oleoyl-phosphatidylcholine (POPC), 1,2-dioleoyl-phosphatidylglycerol (DOPG), L-α-
phosphatidylinositol (PI) from bovine liver, 1,2-dihexanoyl-sn-glycerol-3-
phosphocholine (diC6PC), 1,2-diheptanoyl-sn-glycerol-3-phosphocholine (diC7PC) and 
1,2-dibutyryl-sn-glycero-3-phophocholine (diC4PC).  
2.1.4 Molecular probes  
    Both the fluorescence labeling reagents Alexa Fluor 488 C5 maleimide (for cysteine 
labeling, AF488-Cys) and Alexa Fluor 488 carboxylic acid, succinimidyl ester (for N-
terminal amino group, AF488-N-term), were purchased from Invitrogen. 
2.1.5 Other chemicals 
    Tris(hydroxymethyl)aminomethane (Tris), 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 2-(N-morpholino) ethane-sulfonic acid (MES), 
bovine serum albumin (BSA), dithiothreitol (DTT), β-mercaptoethanol (βME), deuterium 
oxide (D2O), imidazole, sodium phosphate monobasic, sodium chloride, potassium 
chloride, magnesium sulfate, magnesium phosphate, manganese(II) chloride, calcium 
chloride, glycine, sodium pyruvate, ammonium acetate, ammonium sulfate, boric acid, 
ammonium persulfate (APS), N,N,N',N'-tetramethylethylenediamide (TEMED), 5,5'-
dithiobis-(2-nitrobenzoic acid) (DTNB), pyridoxal 5’-phosphate (PLP), chloroform, 
methanol, acetic acid, glycerol, Triton X-100 (TX-100), M9 minimal salts, arabinose, 
leucine, polyethylene glycol 4000 (PEG4000) were obtained from Sigma-Aldrich. The 
2,6-difluorophenol was purchased from ACROS. The Boc-L-pentafluorophenylalanine 
was purchased from Peptech Corporation. LB broth and LB agar were obtained from 
Fisher Scientific. Chloramphenicol, ampicillin and isopropyl β-D-1-
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thiogalactopyranoside (IPTG) were purchased from American Bioanalytical, Inc. The 
detergent compatible (DC) BCA protein assay kit, molecular weight markers, agarose 
and 30% acrylamide/bisacrylamide solution were obtained from Bio-Rad Laboratories.  
2.2 Preparation of fluorinated amino acids 
2.2.1 Preparation of F-F5     
     Boc-L-pentafluorophenylalanine (1 mmol) was dissolved in a mixture of 95/2.5/2.5 
TFA/iPr3SiH/H2O (10mL), and stirred at room temperature for 2 h. The solvents were 
then removed under rotary vacuum, and the residue was lyophilized and directly used for 
cell growth.  
2.2.2 Synthesis of Y-F2 
     Y-F2 was synthesized following established methods [1]. Aliquots (1 mL) of E. coli 
cells for expression of tyrosine phenol lyase (TPL) were provided by Professor Jianmin 
Gao, Boston College.  These were used to inoculate LB media (1 L containing 100 µg/ml 
ampicillin) at 37°C. The protein is constitutively expressed, so no induction is required. 
After 18 h at 37°C, the cells were harvested by centrifugation and re-suspended in 100 
mM potassium phosphate, pH 7.0, 0.1 mM pyridoxal phosphate (PLP), 1 mM EDTA, and 
5 mM β-mercaptoethanol (βME). Cells were lysed by sonication (10 x 30s) and the 
suspensions centrifuged. The clear lysate was used for enzymatic synthesis of Y-F2 .  
     To synthesize Y-F2, the following reaction conditions, in a final volume of 1 L were 
used: 10 mM 2,6-difluorophenol, 60 mM sodium pyruvate, 40 µM PLP, 30 mM 
ammonium acetate and 5 mM βME. The pH of the mixture was adjusted to 8.0 with 
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ammonium hydroxide. The TPL lysate was added and the mixture was stirred at room 
temperature for 4 days in the dark.  
2.2.3 Purification of Y-F2 
    To purify the synthesized Y-F2, the 1L reaction mixture was acidified to pH 3.0 with 
concentrated HCL, which precipitated the TPL. A 2 cm thick celite pad was prepared to 
filter the precipitated protein. The filtrate was extracted twice with 0.5 volume of ethyl 
acetate and the aqueous layer was loaded onto an AG50W-X8 cation exchange column 
(Bio-rad), which was equilibrated with 10 volumes water after pre-equilibration with 2 
volumes of 6 N HCl. The column was then washed with another 8 volumes of distilled 
water. The Y-F2 was eluted with 10% ammonium hydroxide; fraction sizes were 10 mL. 
Fractions that gave a positive ninhydrin (0.19% w/v ninhydrin, 95% v/v butanol, 0.5% 
v/v acetic acid and 4.5% v/v water) test were pooled and the volume reduced to 20 mL by 
rotary evaporation. The remaining solution was lyophilized overnight and stored at 4°C.  
2.3 Cloning, expression and purification of B. thuringiensis and S. aureus PI-PLC 
2.3.1 Cloning and construction of mutant proteins 
    The S. aureus PI-PLC (SaPI-PLC) gene was cloned into a pET21a vector with a C-
terimal His tag by previous lab member, Dr. Jiongjia Cheng. The B. thuringiensis PI-PLC 
(BtPI-PLC) gene was originally cloned in the pHN1403 vector, and obtained from Dr. 
Ming-Daw Tsai (Ohio State University). To simplify the purification and increase the 
yield of fluorinated BtPI-PLC, BtPI-PLC gene was subcloned into a pET23b vector 
(Novagen) and expressed with a C-terminal His tag. 
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Figure 2-1.  Molecular structures of fluorinated aromatic amino acids. (A) pentafluoro-Phe (F-
F5); (B) difluoro-Tyr (Y-F2) 
 
 
 
    An NdeI restriction site was used for cloning the 5’ end of the target gene, with a 
forward primer 5’-ggggaCATATGgctagctctgttaatgagctt-3’ (NdeI site underlined). A 
XhoI restriction site was used for cloning the 3’end of the target gene with a reverse 
primer 5’-gcgaggCTCGAGttcttttattaatgacttata-3’ (XhoI site underlined). Target genes 
flanked with NdeI and XhoI sites were amplified under Taq DNA polymerase by PCR. 
The PCR products were verified on a 1% agarose gel and further purified by the 
QIAquick Gel Extraction kit following the manufacturer’s instructions. The purified 
products and empty pET23b vector were both doubly digested overnight with XhoI and 
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NdeI (New England Biolabs) at 37°C. Incubation for 2 h with alkaline phosphatase  
prevented self-ligation. The Quick ligation kit (New England Biolabs) was used to 
perform direct ligation of the digested PCR product into the empty pET23b vector.  
Molar ratios of 1:3 and 1:5 of vector to insert were tested. The ligation mixture was 
transformed into XL-10 gold competent cells for plasmid propagation and preparation. 
Resulting colonies were grown as minicultures, and purified DNA was sequenced to 
confirm the desired clone. 
    Both BtPI-PLC and SaPI-PLC mutants were constructed using QuikChange 
methodology [2], following the QuikChange instructions provided by Agilent 
Technologies. A pair of complementary primers were designed using the web-based 
program (http://www.genomics.agilent.com/primerDesignProgram.jsp). For mutants 
incorporating F-F5 and Y-F2, an amber codon was introduced into the desired site and 
primers with amber codon in the center were designed. All the primers used are listed in 
Table 2-1. Mutagenesis was carried out using the Quick Lightening site-directed 
Mutagenesis kit (Agilent), which contains PCR PfuTurbo DNA polymerase for primer 
extension and restriction enzyme DpnI for methylated parental DNA digestion. PCR 
products were transformed into XL-10 gold supercompetent cells for plasmid propagation. 
All mutant plasmids were minicultured and purified for DNA sequencing. 
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Figure 2-2. B. thuringiensis PI-PLC DNA and corresponding amino acid sequences. 
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GCTAGCTCTGTTAAT GAGCTTGAAAATTGG TCAAAATGGATGCAA CCTATACCTGATAAT 
 A  S  S  V  N   E  L  E  N  W   S  K  W  M  Q   P  I  P  D  N  
 
ATCCCGTTAGCACGA ATTTCAATTCCAGGA ACACACGATAGTGGG ACGTTCAAGTTGCAA 
 I  P  L  A  R   I  S  I  P  G   T  H  D  S  G   T  F  K  L  Q  
 
AATCCGATTAAGCAA GTGTGGGGAATGACG CAAGAATATGATTTT CGCTATCAAATGGAC 
 N  P  I  K  Q   V  W  G  M  T   Q  E  Y  D  F   R  Y  Q  M  D  
 
CATGGAGCTCGCATT TTTGATATAAGAGGA CGTTTAACAGATGAT AATACGATAGTTCTT 
 H  G  A  R  I   F  D  I  R  G   R  L  T  D  D   N  T  I  V  L  
 
CATCATGGGCCATTA TATCTTTACGTAACA CTGCATGAATTCATA AATGAAGCGAAACAA 
 H  H  G  P  L   Y  L  Y  V  T   L  H  E  F  I   N  E  A  K  Q  
 
TTTTTAAAAGATAAC CCGAGTGAAACAATT ATTATGTCTTTAAAA AAAGAGTATGAGGAT 
 F  L  K  D  N   P  S  E  T  I   I  M  S  L  K   K  E  Y  E  D  
 
ATGAAAGGGGCAGAA GGTTCATTTAGTAGT ACGTTTGAAAAAAAT TATTTTGTTGATCCT 
 M  K  G  A  E   G  S  F  S  S   T  F  E  K  N   Y  F  V  D  P  
 
ATCTTTTTAAAAACA GAAGGAAATATAAAA CTTGGAGATGCTCGT GGGAAAATTGTACTA 
 I  F  L  K  T   E  G  N  I  K   L  G  D  A  R   G  K  I  V  L  
 
CTAAAAAGATATAGT GGTAGTAATGAATCT GGAGGATATAATAAT TTTTATTGGCCAGAT 
 L  K  R  Y  S   G  S  N  E  S   G  G  Y  N  N   F  Y  W  P  D  
 
AATGAGACGTTTACC ACAACTGTAAACCAA AATGTAAATGTAACA GTACAAGATAAATAT 
 N  E  T  F  T   T  T  V  N  Q   N  V  N  V  T   V  Q  D  K  Y  
 
AAAGTGAATTATGAT GAGAAAGTAAAATCT ATTAAAGATACGATG GATGAAACGATGAAC 
 K  V  N  Y  D   E  K  V  K  S   I  K  D  T  M   D  E  T  M  N  
 
AATAGCGAGGATTTA AATCATCTATATATT AATTTTACAAGCTTG TCTTCTGGTGGTACA 
 N  S  E  D  L   N  H  L  Y  I   N  F  T  S  L   S  S  G  G  T  
 
GCATGGAATAGTCCA TATTACTACGCTTCT TATATAAATCCTGAA ATTGCAAACGATATA 
 A  W  N  S  P   Y  Y  Y  A  S   Y  I  N  P  E   I  A  N  D  I  
 
AAACAAAAGAATCCT ACAAGAGTAGGCTGG GTAATTCAAGACTAC ATAAATGAAAAGTGG 
 K  Q  K  N  P   T  R  V  G  W   V  I  Q  D  Y   I  N  E  K  W  
 
TCACCATTATTGTAT CAAGAAGTTATAAGA GCGAATAAGTCATTA ATAAAAGAATAA 
 S  P  L  L  Y   Q  E  V  I  R   A  N  K  S  L   I  K  E  *  
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Figure 2-3. S. aureus PI-PLC DNA and corresponding amino acid sequences. !
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TCAGATTCGTTGAGT AAAAGTCCAGAAAAT TGGATGAGTAAACTT GATGATGGAAAACAT 
 S  D  S  L  S   K  S  P  E  N   W  M  S  K  L   D  D  G  K  H  
 
TTAACTGAGATTAAT ATACCGGGTTCACAT GATAGTGGCTCATTC ACTTTAAAGGATCCA 
 L  T  E  I  N   I  P  G  S  H   D  S  G  S  F   T  L  K  D  P  
 
GTAAAATCAGTTTGG GCAAAGACTCAAGAT AAAGATTACCTTACC CAAATGAAGTCGGGA 
 V  K  S  V  W   A  K  T  Q  D   K  D  Y  L  T   Q  M  K  S  G  
 
GTCAGGTTTTTTGAT ATTAGAGGTAGAGCA AGTGCTGATAATATG ATTTCAGTTCATCAC 
 V  R  F  F  D   I  R  G  R  A   S  A  D  N  M   I  S  V  H  H  
 
GGCATGGTTTATTTG CATCATGAATTAGGA AAATTTCTCGATGAT GCTAAATATTACTTG 
 G  M  V  Y  L   H  H  E  L  G   K  F  L  D  D   A  K  Y  Y  L  
 
AGTGCTTATCCAAAC GAAACAATTGTGATG TCTATGAAAAAGGAC TACGATAGCGATTCT 
 S  A  Y  P  N   E  T  I  V  M   S  M  K  K  D   Y  D  S  D  S  
 
AAAGTTACGAAGACA TTTGAAGAAATTTTT AGAGAATATTATTAT AATAACCCGCAATAT 
 K  V  T  K  T   F  E  E  I  F   R  E  Y  Y  Y   N  N  P  Q  Y  
 
CAGAATCTTTTTTAC ACAGGAAGTAATGCG AATCCTACTTTAAAA GAAACGAAAGGTAAA 
 Q  N  L  F  Y   T  G  S  N  A   N  P  T  L  K   E  T  K  G  K  
 
ATTGTCCTATTCAAT AGAATGGGGGGTACG TACATAAAAAGTGGT TATGGTGCTGACACG 
 I  V  L  F  N   R  M  G  G  T   Y  I  K  S  G   Y  G  A  D  T  
 
TCAGGTATTCAATGG GCAGACAATGCGACA TTTGAAACGAAAATT AATAATGGTAGCTTA 
 S  G  I  Q  W   A  D  N  A  T   F  E  T  K  I   N  N  G  S  L  
 
AATTTAAAAGTACAA GATGAGTATAAAGAT TACTATGATAAAAAA GTTGAAGCTGTTAAA 
 N  L  K  V  Q   D  E  Y  K  D   Y  Y  D  K  K   V  E  A  V  K  
 
AATTTATTGGCTAAA GCTAAAACGGATAGT AACAAAGACAATGTA TATGTGAATTTCTTG 
 N  L  L  A  K   A  K  T  D  S   N  K  D  N  V   Y  V  N  F  L  
 
AGTGTAGCGTCTGGA GGCAGCGCATTTAAT AGTACTTATAACTAT GCATCACATATAAAT 
 S  V  A  S  G   G  S  A  F  N   S  T  Y  N  Y   A  S  H  I  N  
 
CCTGAAATTGCAAAA ACGATTAAAGCAAAT GGGAAAGCTAGAACG GGTTGGCTGATTGTT 
 P  E  I  A  K   T  I  K  A  N   G  K  A  R  T   G  W  L  I  V  
 
GACTATGCAGGATAT ACGTGGCCTGGATAT GATGATATCGTAAGT GAAATTATAGATAGT 
 D  Y  A  G  Y   T  W  P  G  Y   D  D  I  V  S   E  I  I  D  S  
 
AATAAATAA 
 N  K  *  
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Table 2-1. Primers used in site-directed mutagenesis (reverse primers are not listed). !
Mutant& Primer&
BtPI-PLC& !
WT*!(N168C)! 5’-gatatagtggtagtTGTgaatctggagg-3’ 
K38A! 5’-cgatagtgggacgttcGCGttgcaaaatccg-3’ 
K44A! 5’-gcaaaatccgattGCGcaagtgtggggaatg-3’ 
V46K! 5’-ccgattaagcaaAAGtggggaatgacgc-3’ 
R71A! 5’-gatataagaggaGCTttaacagatg-3’ 
K122A! 5’-gagtatgaggatatgGCAggggcagaaggttc-3’ 
K201A! 5’-cagtacaagataaatatGCAgtgaattatgatg-3’ 
K279A! 5’-gactacataaatgaaGCGtggtcaccattattg-3’ 
Y246A! 5’-gcatggaatagtccaGCTtactacgcttc-3’ 
Y247A! 5’-gcatggaatagtccatatGCCtacgcttc-3’ 
Y248A! 5’-gtccatattacGCCgcttcttatataaatcc-3’ 
Y251A! 5’-ctacgcttctGCTataaatcctgaaattgc-3’ 
N203Y! 5’-gataaatataaagtgTATtatgatgag-3’ 
Q40Y! 5’-cgttcaagttgTATaatccgattaagc-3’ 
G238W! 5’-caagcttgtcttctTGGggtacagcatgg-3’ 
Y246A/Y247Aa! 5’-ggaatagtccagctGCCtacgcttcttatataatcc-3’ 
Y86X! 5’-gggccattaTAGctttacgtaacactgc-3’ 
Y88X! 5’-ccattatatcttTAGgtaacactgcatgaattc-3’ 
Y204X! 5’-gataaatataaagtgaatTAGgatgagaaagtaaaatc-3’ 
Y246X! 5’-gcatggaatagtccaTAGtactacgcttc-3’ 
Y247X! 5’-ggaatagtccatatTAGtacgcttcttatataaatcc-3’ 
Y248X! 5’-gtccatattacTAGgcttcttatataaatcc-3’ 
Y251X! 5’-ctacgcttctTAGataaatcctgaaattgc-3’ 
SaPI-PLC&  
F249X! 5’-ggaggcagcgcaTAGaatagtacttataac-3’ 
Y253X! 5’-gcatttaatagtactTAGaactatgcatcac-3’ 
Y253F! 5’-gcatttaatagtactTTTaactatgcatcac-3’ 
H258F! 5’-cttataactatgcatcaTTTataaatcctgaaattgc-3’ 
H258X! 5’-ctatgcatcaTAGataaatcctgaaattgc-3’ 
N254Y/H258Xb! 5’-gtacttattattatgcatcaTAGataaatcctgaaattgc-3’ 
!
*!All the other BtPI-PLC mutant primers were based on N168C plasmid.   
a This mutant was designed using Y246A as the parent plasmid. 
  b This mutant was designed using N254Y/H258Y as the parent plasmid. 
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2.3.2 Expression of native and unnatural amino acid containing PI-PLCs 
    The appropriate sequenced plasmid was transformed into BL21-codonplus (DE3)-RIL 
competent cells using the heat-shock method. A single colony was used to inoculate a 
5ml LB media and the culture was shaken at 37°C overnight in the presence of 
appropriate antibiotics (34 µg/mL chloroamphenicol and 100 µg/mL ampicillin). This 
small culture was used to inoculate 1 L LB (with 34 µg/mL chloroamphenicol and 100 
µg/mL ampicillin). Recombinant PI-PLC overexpression was induced by the addition of 
0.8 mM IPTG (except for cysteine mutant where 0.4 mM IPTG were used) when the 
OD600 reached 0.7-0.8. The induced cell culture was incubated for another 20 h at 16°C. 
Cells were harvested by centrifugation and frozen at −20°C for storage. 
     To express PI-PLCs that incorporat F-F5 or Y-F2, E. coli BL21(DE3) Star one shot 
cells were cotransformed with pEVOL-pylT-PyIRs/pEVOL-F2YRS and mutant 
plasmids. A single colony was then selected and used to inoculate 30 mL of GMML 
supplemented with 34 µg/mL chloroamphenicol and 100 µg/mL ampicillin. Cells were 
grown at 37°C in an incubator (250 r.p.m.) and protein expression was induced when 
OD600 reached 0.6 by adding 1mM IPTG, 0.2% arabinose and 1mM F-F5 or Y-F2. The 
induced cell culture was incubated at 37°C for another 12 h. Cells were then harvested 
and frozen at −20°C for storage. 
2.3.3 Purification of BtPI-PLC 
    Cell pellets were suspended in 20 mM Tris-HCl, pH 8.9, placed on ice and lysed by 
sonication. Cell debris was pelleted by centrifugation at 15,000 rpm (using a JA-17 rotor) 
for 35 min. The supernatant containing the enzyme was dialyzed against 20 mM Tris-
HCl, pH 8.9 overnight, then it was applied onto a Q-sepharose fast flow (QFF) column 
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(15 mm x 15 cm) equilibrated with 20 mM Tris-HCl, pH 8.9. The PI-PLC protein was 
eluted using an increasing NaCl gradient from 0 to 0.6 M in 20 mM Tris-HCl, pH 8.0 at 
the flow rate of 2 mL/min. Fractions were collected and analyzed by SDS-PAGE (12% 
gels) to identify those with BtPI-PLC. The protein was further purified using a phenyl-
sepharose column (10 mm x 10 cm) equilibrated with 1 M NaCl in 20 mM Tris-HCl, pH 
8.0. After the protein was loaded on the column, the PI-PLC was eluted with a decreasing 
NaCl gradient from 1.0 to 0 M at the flow rate of 1 mL/min. Fractions containing PI-PLC 
were collected and dialyzed against 20 mM Tris-HCl, pH 8.0, and then concentrated by 
using Vivaspin 20 mL 10 kDa cut-off filters (Vivaproducts, Inc). Purity of PI-PLC 
variants was >90% as monitored by SDS-PAGE. Protein concentrations were measured 
by both Lowry assays and the absorption at 280 nm. Extinction coefficients at 280 nm 
were calculated using the ProtParam tool  (http://web.expasy.org/protparam [3]). For 
fluorescence correlation spectroscopy (FCS) experiments, a single Cys residue, N168C, 
was introduced into the protein. For these cysteine-containing proteins, DTT was added 
during the purification process and in the storage buffer. 
2.3.4 Purification of unnatural amino acid containing PI-PLCs 
   Both His-tagged BtPI-PLC and SaPI-PLC were purified in the same way. The cell 
lysate with enzyme was prepared by suspending cell pellets in 40mL buffer of 20 mM 
Tris-HCl, 10 mM imidazole, pH 8.5, followed by sonication and then centrifugation. The 
cell extract was loaded onto a Ni-NTA agarose column at the flow rate of 0.4 ml/min 
then washed using 200 mL buffer (20 mM Tris-HCl, 10 mM imidazole, pH 8.5) at the 
flow rate of 1 mL/min and further washed with 200mL buffer at 2 mL/min. The UV 
signal was monitored during the washing and elution steps. The His-tagged protein was 
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eluted using 0.01 to 0.15 M imidazole gradient in 20 mM Tris-HCl, pH 8.5. Protein 
purity was monitored by SDS-PAGE and fractions with greater than 90% purity were 
pooled and concentrated. The concentrations of the PI-PLC enzymes were measured by 
the absorption at 280 nm using the calculated ProtParam tool. 
2.4 CD Spectroscopy to monitor protein stability and overall folding 
    Secondary structure content and thermal stability of the PI-PLC variants were 
measured using far-UV circular dichroism (CD) spectra obtained on a model AVIV No. 
202 CD spectrophotometer. All samples used for CD experiments were prepared by 
adding the desired amount of protein (0.05 mg/mL) to 10 mM borate, pH 8.0. In the 
wavelength scanning experiments at 25 oC, CD spectra were collected from 300 to 180 
nm with 1 nm wavelength steps. Secondary structure content was analyzed with the 
CDNN program [4] using the calculated molar ellipticity in the 190-260 nm range. 
Thermal stabilities for all proteins were measured by monitoring the ellipticity at 222 nm 
(primarily α-helix) while increasing the sample temperature 1.0 oC per min from 20 to 90 
oC, with 1 min equilibration time at each temperature. 
2.5 Mass spectrometry to confirm the desired incorporation of F-F5 and Y-F2 
    Samples were analyzed using instrumentation at the University of Massachusetts Mass 
Spectrometry Center. Samples were dissolved initially in water and then diluted to 1-10 
µM in acetonitrile/water/acetic acid (50:47:3 v/v/v). Intact protein molecular weights 
were determined with a MicrOTOF II ESI-TOF mass spectrometer (Bruker Daltonics, 
Inc.) using electrospray ionization in positive mode.  MS/MS data were obtained using a 
SolariX 7T FT-ICR (Bruker Daltonics) using CID in the storage quadrupole (~ 5 V 
collision energy). The most intense charge state peak [M+43H]43+ was selected for 
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isolation. Although complete top-down fragmentation data were not obtained, 
representative fragments enabled the site of modification to be confirmed.  Interestingly, 
the fluorinated analogs tended to fragment with a significantly lower (2-3 V) collision 
energy and resulted in a quite different fragmentation pattern from the non-fluorinated 
version.  
    MS analysis of tryptic peptides was required to identify the position of the Y-F2 in 
N254Y/H258Y-F2. Tryptic peptides were also used to confirm the position of the 
fluorinated amino acid in H258F-F5.  
2.6 19F NMR to monitor fluorinated amino acid incorporation 
    19F NMR was used to characterize the successful incorporation of the fluorinated 
aromatic amino acids in both Bt and Sa PI-PLCs. Appropriate amount of concentrated 
protein were frozen in liquid N2, and then lyophilized overnight. The dried protein was 
rehydrated with Tris buffer (pH 8.5) to yield a final 0.2mM sample for 19F NMR 
detection. Denaturation of samples in 2% SDS was also used in attempts to simplify the 
otherwise broad and powder-like 19F spectra obtained using a Varian VNMRS 600 
spectrometer. Acquisition parameters include 4.9 µs pulse width (90°), 8012.8 Hz sweep 
width, 1 delay time between pulse+acquisition times, and 10000 transients collected. 
Spectra were Fourier transformed with 25 Hz linebroadening.  
2.7 Preparation of phospholipid vesicles 
    Small unilamellar vesicles (SUVs) used in enzyme kinetic experiments were prepared 
by sonication using a Branson Sonifier 250. The composition of the SUVs (PI, PI/PC, 
PG/PC) is noted by XPC, the mole fraction of PC. Aliquots of phospholipids species in 
chloroform were mixed, then dried under N2. The resultant film was lyophilized 
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overnight and stored at −20°C. The lipid film was rehydrated with appropriated buffer 
and the phospholipid solution was sonicated on ice for 30 x 20s, with a 20s rest between 
each sonication. The average radius for PI and PI/PC (XPC =0.5) vesicles characterized by 
DynaPro NanoStar Dynamic Light Scattering (DLS) instrument (Wyatt Technology 
Corp) was 130 Å. Similar average radii for PG/PC SUVs were also documented. [5,6] 
2.8 PI-PLC enzyme acitivity assayed by 31P NMR spectroscopy 
    Specific activities of the PI-PLC enzymes were measured by 31P NMR spectroscopy 
[7-10] using a VNMRS 600 spectrometer. For BtPI-PLC, the activity assay was usually 
carried out in 50 mM HEPES pH 7.5, 1 mM EDTA, and 0.1 mg/mL bovine serum 
albumin (BSA) at 28 oC.  For SaPI-PLC, it was carried out in 50 mM MES, pH 6.5, with 
EDTA and BSA at 28 °C. The BSA was used to stabilize the protein at the very low 
concentrations used in these assays. The amount of enzyme added into different assay 
systems was adjusted so that <20% cyclic inositol phosphate product (cIP) was generated 
in 15 min for the fixed time method. The amount of BtPI-PLC used was typically 0.1–
0.25 µg/mL for mixed micelle assays, 0.2–2 µg/mL for PI cleavage when presented in 
vesicles, SaPI-PLC concentrations used in assays ranged from 0.3 to 4 µg/mL. The 
increase in cIP under these conditions is linear with time indicative of an initial rate being 
measured. Because we are dealing with a vesicle and some fusion of SUVs as 
diacylglycerol (DAG) is produced, this is not the same as a steady-state rate with the 
substrate in solution, but it is operationally useful for comparing rates under different 
conditions (pH, concentration of enzyme, salt, etc.). Mixed micelles of PI with Triton X-
100 (TX-100) or diC7PC were prepared by addition of the detergent solution to dry PI 
which will turned optically clear after mixing. Mixed micelles examined were either PI (8 
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mM)/TX-100 (16 mM) or PI (8 mM)/diC7PC (32 mM) for BtPI-PLC and PI (4 mM)/TX-
100 (8 mM) or PI (4 mM)/diC7PC (16 mM) for SaPI-PLC. For the specific activities of 
PI-PLCs toward PI in small unilamellar vesicles (SUVs), the enzyme and SUVs were 
incubated for a fixed length of time at 28 oC. The reaction was then quenched by the 
addition of a few drops of acetic acid (dropping the pH below 4) followed by TX-100 
addition to solubilize the remaining lipids in mixed micelles. The relative integrated 
intensity of the cIP resonance versus the total phospholipid concentration (initial [PI] or 
[PI] + [PC]) was used to calculate PI-PLC specific activity (as shown in Fig. 2-4). For the 
enzymatic assays of cysteine mutant variants, 5 mM DTT was added to avoid formation 
of any protein dimers. 
 
Figure 2-4. Characterization of PI-PLC enzymatic reaction by 31P NMR. All the phosphorus 
species involved in the assay system are identified with arrows, including phosphatidylinositol 
(PI), phosphatidylcholine (PC), inositol 1,2-cyclic phosphate (cIP) the amount of enzyme was 
added so that less than 20% product was generated. XPC=0.2. 
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2.9 PI-PLC labeling with Alexa Fluor 488    
    Fluorescent labeling of proteins was carried out according to the manufacturer’s 
protocol (Invitrogen); schemes for labeling chemistry are shown in Fig. 2-5. For BtPI-
PLC, N168C mutant proteins were specifically labeled at Cys168 with the hydrophilic 
dye Alexa Fluor 488 C5 maleimide (AF488-Cys). AF488-Cys was briefly centrifuged 
and prepared as a 25 mM stock solution in anhydrous DMSO and stored at −20°C until 
use. Prior to labeling, the proteins were incubated with 5 mM DTT at room temperature 
for 30 min to reduce any disulfide bonds. The excess DTT was removed using Micro 
Bio-Spin 6 columns, which were pre-equilibrated with 0.5mL buffer (20 mM Tris-HCl, 
pH 7.0). The dye was added immediately (mole ratio of dye:protein=3:1 to 5:1) and the 
solution was incubated in the dark at room temperature for 2 h. For different proteins, 
different amounts of dye and incubation time were needed for optimal labeling efficiency. 
For SaPI-PLC, proteins were labeled with Alexa Fluor 488 carboxylic acid, succinimidyl 
ester (AF488-N-term). AF488-N-term dye was prepared as a 10 mM stock solution in 
anhydrous DMSO. This dye was added into the protein sample at a mole ratio of 
dye:protein = 5:1. To maximize preferential labeling of the N terminus rather than lysine 
residues, the SaPI-PLC protein labeling reaction was carried out in phosphate buffer, pH 
7.2. Unbound dye was removed using three micro-spin columns. The absorptions at 280 
nm for protein plus dye and at 495 nm for the dye were used to estimate the labeling ratio. 
The equation used for calculating the labeling ratio was:  
[D]/[P]=(εp /εd)*A495/(A280 – 0.1A495) 
where εp was the extinction coefficient of PI-PLC at 280 nm (refer to 2.3.3), εd was the 
extinction coefficient of AF488 at 495 nm (71,000 cm-1 M-1) and 0.1 A495 was the 
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correction. All the BtPI-PLC variants had a labeling ratio of 100±10%, and the SaPI-
PLCs typically had 90–100% dye incorporation.  
 
 
Figure 2-5. Labeling schemes for Alexa Fluor 488 dyes. (A) Cysteine labeling with Alexa Fluor 
488 C5 maleimide; (B) N-terminus labeling with Alexa Fluor 488 carboxylic acid, succinimidyl 
ester. 
 
 !  
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2.10 Binding of PI-PLCs to vesicles measured by fluorescence correlation 
spectroscopy (FCS) 
    FCS based binding assays were performed using a previously described [6] home-built 
confocal setup based on an IX-70 inverted microscope (Olympus) as shown in Fig. 2-5. 
Alexa Fluor 488 (AF488) fluorescence was monitored at 22 oC with samples placed in 
chambered coverglass wells (Lab-Tek, Nunc), containing 10 nM labeled BtPI-PLCs plus 
1 mg/mL BSA in 300 µl PBS, pH 7.4 for BtPI-PLC; binding experiments with SaPI-
PLCs used 3.5 nM labeled protein and 1mg/ml BSA in 300 µl of 50 mM MES, pH 6.5. 
Prior to use, the chambers were coated with 10 mg/mL BSA and rinsed with desired 
buffer to prevent protein adhesion to the sides of the walls. The anionic substrate analog 
DOPG was used for all FCS experiments because the PI cleavage product DAG leads to 
vesicle fusion [7]. PG is a BtPI-PLC substrate and can be cleaved over a period of days 
by mg/mL concentrations of PI-PLC. [8] However, at the low protein concentrations used 
in the FCS experiments, no detectable hydrolysis of PG occurred. To assess protein 
binding, SUVs containing DOPG and various mole fractions of POPC, XPC, were titrated 
into the labeled PI-PLC solutions and fluorescence intensities were collected. For each 
XPC, FCS titrations were run in triplicate and repeated a second time with different 
vesicle and protein preparations.  
    Data were analyzed as previously described [9-10]. The fitted diffusion coefficient for 
free, AF488-Cys labeled BtPI-PLC was 54±5 µm2 s-1 and AF488-N-term labeled SaPI-
PLC (Dfree) was 50±2 µm2 s-1; the vesicle diffusion coefficient, Dbound, determined from 
analysis of vesicles containing fluorescently labeled Rhodamine lipids, was in the range 
of 12-15 µm2 s-1.  
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Figure 2-6. FCS experimental schematic. Individual laser lines from an air-cooled argon-krypton, 
multi-line laser are separated using a quartz prism P. The 488 nm laser line is isolated and 
expanded 5 times using two lenses, L1 and L2, in order to be reflected into the sample using a 
500drlp dichroic D1. In the IX-70 inverted microscope, the 60X water objective, Obj, focuses the 
laser light into the sample and collects the emission. The emission passes through D1 and any 
remaining scattered laser light is blocked by a HQ505lp long pass filter F1. The emission is then 
focused onto a 30µm pinhole by the tube lens L3 in the microscope to limit the detection volume 
and collimated by lens L4. To calculate the cross-correlation, the fluorescence signal is split by a 
50-50 beam splitter, BS2, and passes through HQ535/50 bandpass filters, F2 & F3, to be focused 
on two avalanche photodiodes, APD1 and APD2, by lenses L5 and L6, respectively. The box 
shows a typical observation volume (1 µm3) with different species, free AF488 labeled protein 
and vesicle-bound AF488 labeled protein, diffusing in and out of the volume (as indicated in the 
cartoon on the right).  
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Figure 2-7. Representative normalized correlations and binding curves for *WT BtPI-PLC. (A) 
Normalized correlation curves for 10 nM *WT BtPI-PLC in solution (red), in the presence of 100 
µM PC SUVs (open square), 400 µM PC SUVs (solid circle), 4700 µM PC SUVs (open circle) 
and fluorescent labeled PC SUVs (solid triangle). (B) Titration curves showing the fraction of 
*WT BtPI-PLC bound to pure POPC SUVs (blue), DOPG/POPC (XPC = 0.25) SUVs (orange). 
Error bars represent the S.D. from 3 independent sets of titrations.!!
!
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2.11 X-ray crystallography of SaPI-PLC mutants H258F-F5 and F249F-F5 
    H258F-F5 and F249F-F5 were concentrated to 20 mg/mL and then combined with 200 
mM myo-inositol. Before setting up crystallization trays, the protein solution was diluted 
to a final concentration of 10 mg/mL, with 100 mM myo-inositol and incubated on ice for 
a minimum of 2 h. The PI-PLC samples were crystallized at 4 °C by vapor diffusion, 
using 3 µL hanging drops against a reservoir solution containing 150 mM ammonium 
acetate, 100 mM sodium acetate, pH 4.6, with 10 mM magnesium nitrate, and 20-24% 
PEG 4000.  
    Data were collected at 100 K using a Rigaku MicroMax-07 HF high-intensity 
microfocus rotating Cu anode X-ray generator, coupled with Osmic VariMax Optics and 
a R-Axis IV++ image plate area detector. Data were indexed and reduced using d*TREK 
[12].  Both structures were solved by doing molecular replacement in PHENIX [13], 
using PHASER [15], with the S. aureus structure 3V18 as a starting model. All models 
were refined with Phenix.refine, with manual model building in COOT [14].  Maps were 
generated in PHENIX. Structural comparisons were made using SSM superposition [16] 
in COOT and alignment in Pymol [17]. Adit [18] was used for PBD deposition and 
validation.  
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Chapter 3  
PC-cation/Tyrosine-π interactions in BtPI-PLC 
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3.1 Introduction 
    Cation-π interactions are ubiquitous noncovalent interactions. They have been 
recognized as a major force for molecular recognition, playing an important role in 
macromolecule structure formation and stability as well as function [1-3]. In protein, 
cation-π interactions are typically observed between aromatic amino acid (phenylalanine, 
tryptophan, or tyrosine) sidechains and cationic ammonium or guanidinium groups from 
lysine and arginine [4]. Cation-π interactions are also important for substrate and ligand 
binding, particularly for molecules containing a choline group. For example, in the 
crystal structure of the human phosphatidylcholine transfer protein (PC-TP), the choline 
moiety of the lipid was involved in cation-π interactions with a cage of three tyrosine 
residues.  
    Cation-π interactions with phospholipids in cell membranes have been suggested to 
play a role in the structural stability and lipid specificity of integral membrane proteins. 
Using gramicidin dimer as a model for integral membrane proteins containing interfacial 
Trp residues for molecular dynamic simulations [5], Petersen and coworkers have shown 
that phosphatidylethanolamine (PE) and PC interact with interfacial tryptophans via 
cation-π interactions. Trp involvement in cation-π interactions with the membrane has 
also been observed in other simulations, both for short peptides [6,7] and for an 
amphitropic protein [8].  
    Compared to integral membrane proteins, peripheral membrane proteins do not span 
the lipid bilayer. They bind at the surface of cell membranes in order to perform their 
function. Thus the protein interactions with the phospholipid headgroups accounted for 
most of their affinity for the membranes. Tyrosine residues, like Trp, can in principle 
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engage in cation-π interactions with choline-containing lipids [9]. However, much less is 
known about these contributions to membrane binding by proteins. Recently, we reported 
that the SaPI-PLC mutant N254Y/H258Y, constructed to contain a four Tyr strip 
mimicking BtPI-PLC, exhibits greatly enhanced affinity for PC-containing membranes. 
In addition, both a X-ray crystal structure [10] and field cycling 31P NMR [11] results 
showed that a specific PC binding site has been introduced into this phospholipase. 
    BtPI-PLC has a plethora of Tyr residues in the protein membrane interface. To 
investigate the cation-π contributions of these residues, a method of combined MD 
simulation and mutagenesis studies was adopted.  
3.2 BtPI-PLC has much tighter vesicle binding than SaPI-PLC  
    SaPI-PLC binds to PC-rich membranes with much lower affinity than does the BtPI-
PLC, and it has virtually no affinity for pure PC vesicles [12]. For BtPI-PLC, increasing 
XPC up to 0.8 increases the protein affinity for SUVs, yielding µM Kd values [13]. In 
contrast, SaPI-PLC binds SUVs at acidic pH, with mM Kd values [12]. Structural 
alignment shows that BtPI-PLC has more surface tyrosine residues compared to SaPI-
PLC. The two long α-helices, F and G, as well as the neighboring α-helix B regions of 
BtPI-PLC contain at least eight Tyr (Tyr86, Tyr88, Tyr200, Tyr204, Tyr246, Tyr247, 
Tyr248, Tyr251) and two Trp (Trp47, Trp242). Previous mutagenesis data for some of 
the helix G Tyr residues [14] showed that these aromatic residues are associated with 
tighter binding of BtPI-PLC to PC-containing vesicles. These tyrosines could be involved 
in cation-π interactions with the choline head group of membrane PC. To bolster this 
interpretation, the SaPI-PLC mutant N254Y/H258Y was constructed based on sequence 
and structural alignments of BtPI-PLC and SaPI-PLC enzymes to mimic a Tyr strip 
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(246Y-Y-Y-A-S-251Y) that is suggested by fc-P-NMR to be around the PC binding site for 
BtPI-PLC [14]. The binding affinity of SaPI-PLC N254Y/H258Y was 50-fold higher than 
WT at XPC=0.8 and showed measurable binding affinity for pure PC vesicles [11]. 
However, even N254Y/H258Y is a much weaker vesicle binder when compared to BtPI-
PLC. The research goal of this project was to define the cation-π interactions between the 
BtPI-PLC and the PC containing SUVs. 
3.3 Molecular Dynamics (MD) simulations 
     Dr. Cedric Grauffel from University of Bergen, Norway, did all the MD simulations 
for BtPI-PLC. Initially, simulations were carried out by docking BtPI-PLC to an implicit 
anionic membrane model to predict the orientation of the protein at the membrane. Six 
PI-PLC orientations relative to the membrane, with each orientation corresponding to one 
face of a cube containing the enzyme, were screened. Half of these orientations led to an 
anchored PI-PLC at the model membrane. It was found that the anchorage was always 
achieved via helix B, in agreement with Dr. Mingming Pu’s previous experimental data 
[13]. The simulation yielding the lowest IMM1-GC effective energy was then selected 
for further analysis. Decomposition of the binding energy shows that the hydrophobic 
interactions with residues in helix B contribute the most energy. It was also found that the 
interfacial Tyr residues showed no significant energetically favorable interactions with 
the implicit membrane, despite their proximity to the membrane plane. Considering that 
implicit membrane model has been reported to underestimate the interfacial interactions 
of aromatic amino acids, Dr. Grauffel switched simulation models to 
dimyristoylphosphatidylcholine (DMPC) bilayers. 
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    Simulations of protein with an all-atom DMPC lipid bilayer were initiated using the 
BtPI-PLC orientation predicted by the implicit membrane simulations. BtPI-PLC showed 
very little structural change during the 500 ns MD simulation. Amino acid anchorage 
depth at the interfacial binding site was evaluated by calculating the distance between the 
residue centers of mass and the average plane defined by the position of the phosphorus 
atoms. The most deeply buried amino acids were located on helix B (Ile43, Pro42, Asn41) 
and on the β7-αG loop (Trp242, Thr240, Ala241 and Gly239), with an average 
penetration depth of 2 to 4 Å inside the plane defined by the phosphorus atoms (Figure 3-
1A). Other amino acids of the interfacial binding site, including most tyrosines, were 
located on the other side of the phosphate plane.  
    Interactions between PI-PLC residues and the membrane phospholipid were monitored 
during the MD simulations. They showed that the frequency of aromatic amino acids, 
especially tyrosines, at the interface between PI-PLC and the membrane is strikingly high. 
Potential cation-π interactions between choline head group and aromatic groups were 
identified. The MD results suggested that the cation-π interactions involving Tyr88 and 
Tyr246 have the highest occupancy. Tyr86, Tyr118, Tyr204 and Tyr251 are involved in 
less persistent cation-π interactions that occur regularly throughout the simulation (Figure 
3-1B). Tyr53, Tyr 247 and Tyr248 were observed mediating cation-π interactions with 
much less frequency. Tyr200 formed an interaction with the choline group of a lipid that 
occasionally sticks out of the bilayer and half-way into the active site. Among the four 
tyrosines (246, 247, 248 and 251) in helix G, three were involved in cation-π interactions 
(the exception was Y248, which has very low occupancy according to the simulations) 
and Y246 and Y251 were suggested to have rather strong interactions. Due to the 
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consecutive location on an α-helix, the side chains of Tyr246, Tyr247 and Tyr248 point 
in different directions and would interact with different lipids. However, the sidechains of 
Tyr247 and Tyr251 are on the same side of the helix, separated by one turn.  
 
Figure 3-1. MD simulations of BtPI-PLC binding to a DMPC bilayer. (A) IMM1 orientation of 
PI-PLC used to initiate the simulations with explicit lipids. Helices B, F and G are magenta, green 
and orange, respectively. (B) Occupancies of cation-π interactions for aromatic residues versus 
simulation time (occupancies >5% are shown). (C) Snapshot of a cation-π interaction collected 
along the simulation time course (representative frame taken between 400 and 500 ns). 
 
 
 
 
 
 
 
 
 
Thus, Tyr247 and Tyr251 could interact with the same phospholipid. Similarly, the 
orientations of Tyr204 on helix F and Tyr251 on helix G allow simultaneous interactions 
! 54!
with the same lipid (Figure 3-1C). Tyr248, also at the interfacial binding site, plays a 
slightly different role. It is almost never involved in interactions with phospholipid. 
Instead, it engages in long-lived intramolecular hydrophobic interactions with Leu235 
and Pro245 that appear to maintain the structure and orientation of the rim loop.  
3.4 Design and characterization of Tyrosine mutants 
    The MD simulation with a DMPC bilayer identified Tyr residues in the loop between 
β2 and helix D (86, 88), in helix F (204) and in helix G (246-247, 251) as important for 
cation-π interactions with PC choline head groups. These MD predictions were tested by 
mutating each Tyr to Ala or Ser, and measuring protein binding to SUVs using FCS. 
Tyr248, which appears to play a different role, was also tested. We also tried to design 
new cation-π interactions by introducing new Tyr or Trp into the rim loop region (at 
resides 40, 88, 203 and 238) of BtPI-PLC. Mutants were constructed using site-directed 
mutagenesis and purified as previously described in Chapter 2, section 2.3. Secondary 
structure and thermal stability of the BtPI-PLC variants were measured and all variants 
are well folded with similar CD spectra (Figure 3-2) and had no significant changes in 
secondary structure (Table 3-1). Thermal stabilities for all PI-PLC variants were similar 
to WT, except for Y204A containing mutants, which are less stable. Other helix B and 
rim loop mutants, including Y86A, Y88A, Y204S and Y248A, were made previously in 
the group by Dr. Su Guo. These were also included in studies of the effects of Tyr!Ala 
mutations. 
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Figure 3-2. Comparison of CD spectra for WT (!) and Y246A ("). Similar agreement with the 
WT far UV CD data is observed for all of the BtPI-PLC mutants. 
 
 
 
Table 3-1. Analysis of PI-PLC secondary structure and thermostability from far-UV circular 
dichroism (CD) data. 
 
Varianta α-helix(%) β-sheet  (%) β-turn (%) 
Random 
coil (%) Tm (°C) 
WT* 22.2 30.0 17.5 29.9 56.7 
Y86A/Y88A* 19.1 34.1 17.1 29.7 56.5 
Y204A/Y251A* 18.6 33.6 16.8 31.1 53.7 
Y204S/Y248A* 21.8 31.5 17.5 29.1 52.9 
Y246A* 20.9 31.6 17.2 30.2 53.1 
Y247A* 19.5 34.3 17.2 29.1 52.6 
Y246A/Y247A* 19.6 34.0 17.2 29.3 51.9 a!The asterisk indicates that all variants contain the N168C mutation required for 
fluorescent labeling.  
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Figure 3-3. Approximate membrane binding geometry suggested by the explicit MD simulation.  
Important residues and helices B, F and G are labeled. The membrane is represented by a blue 
line.  Top view is used here. 
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3.5 Effects of specific mutations on BtPI-PLC binding to vesicles 
    BtPI-PLC binds to SUVs with lower affinity for SUVs composed of pure anionic lipids 
or pure PC SUVs. Because of this apparent synergism, binding was measured as a 
function of XPC (the mole fraction PC in the SUVs). The apparent Kd and ratio of the 
apparent Kd relative to the Kd for wild type (WT) protein are plotted in Figure 3-4 as a 
function of XPC. Apparent Kd values at XPC = 1 are listed in Table 3-2. 
    In general, WT* PI-PLC and the Tyr* variants, (where the asterisk indicates the 
N168C mutation required for Cys-mediated fluorescent labeling of PI-PLC for FCS) have 
similar affinities for anionic SUVs containing only PG (Figure 3-4), and Tyr* defects in 
binding are greatest for SUVs at high XPC. This is consistent with the simulations where 
most of the Tyr residues can mediate interactions with choline headgroups. 
    Both Tyr86 and Tyr88 are at the top of the barrel rim and could directly interact with 
membrane bilayer. Mutagenesis of Tyr88 to Ala (Y88A*) increases the apparent Kd by at 
least one order of magnitude for XPC>0.5 while defects in binding of Y86A* are barely 
significant (Figure 3-4A). As might be expected, decreases in membrane affinity for the 
Y86A/Y88A* double mutant are dominated by the effect of mutating Tyr88. These 
results are consistent with the simulations where, compared to Tyr86, occupancies of 
cation-π interactions between Tyr88 and choline headgroups are much higher and are 
stabilized by additional interactions mediated by the phosphate group of the same 
phospholipid. It also suggests that, consistent with the MD simulations, Tyr86 is slightly 
farther away from the hydrocarbon boundary than Tyr88, which would result less 
interaction with choline head groups and consequently result in less PC dependence. It 
has been shown that the interactions between BtPI-PLC and membranes are very dynamic 
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as shown in the single molecule spectroscopy measurement [15], so the difference of 
Y86A* and Y88A* is more likely caused by the slightly deeper insertion of Tyr88 into 
the interfacial region of the membrane. 
 
Figure 3-4. Binding of BtPI-PLC Tyr variants to SUVs. Apparent Kd (A) and apparent Kd relative 
to WT* (B, C and D) as a function of XPC. The error bars are the largest uncertainties generated 
during the FCS data analysis, either the standard deviations from two independent repeats or the 
uncertainty generated by error propagation for the two independent data sets. 
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    Tyr246 and Tyr247 are both on helix G. The Y246A* variant shows significant 
binding defects even at XPC = 0.2 (Figure 3-4C). Mutagenesis of Tyr247 is much less 
perturbing, and Y247A* has apparent Kds that at most 5-fold higher than WT* at XPC > 
0.8. Y246A* has apparent Kd values more than 60-fold larger than WT* at the same XPC. 
As expected from these results, the double mutant, Y246A/Y247A*, has reduced binding 
affinity similar to that seen for Y246A*. This result is in consistent with the simulations 
where Tyr246 cation-π interactions have higher occupancies while Tyr247 mediates 
fewer cation-π interactions. 
    As for Tyr 204, Tyr248 and Tyr251, the binding results are more complicated. The 
Tyr204 and Tyr251 variants behave similarly (Figure 3-4D). Mutagenesis of either Tyr 
residue has little effect on binding at XPC = 0 or 0.2, but increases the apparent Kd  5-fold 
for XPC = 0.5 and at least an order of magnitude for vesicles with higher PC content. 
Additionally, the double mutant behaves similarly to either single mutant suggesting that 
the effects of these two mutations may not be cooperative. In both the S. aureus 
N254Y/H258Y structure (where S. aureus PI-PLC residues 254 and 258 correspond to B. 
thuringiensis PI-PLC residues 247 and 251, respectively), and in the simulations with 
DMPC, Tyr residues corresponding to BtPI-PLC 204 and 251 can interact with the same 
choline ion diffused into the crystal. Thus, the mutagenesis data with the BtPI-PLC 
suggest that disrupting one of these interactions may be sufficient to disrupt the other.  
    Mutating Tyr residues at positions 88, 246 or 248 has the largest effects on binding 
(Figure 3-4). However, unlike Tyr88 and Tyr246, whose experimental binding data 
correspond well with the MD simulation, the simulations and binding results for Y248A 
mutant do not correlate well. The serious losses in binding affinity for the Y248A* 
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variant when XPC > 0 (Figure 3-4D) suggest that either the simulation underestimates the 
extent of interactions between 248 and PC or Tyr248 engages in other intramolecular 
interactions that stabilize the membrane-bound structure of the protein. The simulations 
indeed suggested Tyr248 was involved in other contacts that helped stabilize the 
orientation of the loop between β-strand 6 and α-helix G in water as shown in Figure 3-5. 
From the superposition of the three structures for WT and Y248A, it is clear that Tyr248 
is critical for stabilizing the β7-αG loop in an orientation that is likely critical for correct 
membrane binding. 
 
Figure 3-5. Structure of the interfacial binding sites of (A) WT PI-PLC and (B) Y248A after 20 
ns MD simulations in water, from three independent simulations in each case. 
 
 
 
 
     
    Combining the large effect of mutating either of these Tyr with the field cycling NMR 
data [16], as well as the engineered PC binding site in SaPI-PLC N254Y/H258Y, we 
suggested that Tyr246, possibly aided and abetted by Tyr204 or Tyr251, forms the 
specific PC binding site that persists for at least one µs in the NMR experiments. The MD 
simulations only lasted a total of 0.5 µs. The fc-P-NMR did not reliably detect a 
persistent PC-Tyr88 interaction in 1:1 PMe (the anionic lipid analogue for PG since over 
! 61!
very long times PG is cleaved by the enzyme) /PC SUVs. Thus, even though the 
simulations with DMPC suggested such interactions occur, the NMR suggests that in the 
presence of significant anionic phospholipid, the Tyr88-PC choline interaction is not 
favored. 
    Since so many of the interfacial Tyr appeared to interact with choline, we decided to 
see if we could introduced a new cation-π site that would presumably enhance binding of 
BtPI-PLC to vesicles. We mutated Gly238 and Tyr88 to Trp with the rationale that a 
larger aromatic residue might facilitate cation-π binding. Asn203 and Gln40 were 
mutated to Tyr since it looked like we could make these changes and not alter the other 
cation-π interactions of the protein with the bilayer. As shown in Figure 3-6, variant 
N203Y* shows a similar binding behavior to WT* protein, while all of the other variants 
G238W*, Y88W* and Q40Y* exhibit lower affinity than WT* at high XPC. These results 
suggest that we failed to introduce new cation-π interactions to the system, which again 
indicates both the position and the local environment, including orientation, local 
conformation and mobility of the aromatic residue matter in order to design new cation-π 
interactions.  
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Figure 3-6. Apparent Kd of BtPI-PLC rim loop region relative to WT* as a function of XPC. The 
error bars are the largest uncertainties generated during the FCS data analysis, either the standard 
deviations from two independent repeats or the uncertainty generated by error propagation for the 
two independent data sets. 
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3.6 Specific enzymatic activity of Tyr mutants 
    Since most of the Tyr ! Ala mutants had binding defects, it was of interest to see how 
this affected the enzymatic activity of PI-PLC. The phospholipase assays were performed 
using lipid concentrations that are 1.79 to 1250 times higher than the apparent Kd values 
for PG/PC SUVs, insuring that almost all of the protein partitions onto the vesicles in the 
presence of PC. All of the PI-PLC Tyr variants showed the same activity pattern as WT* 
(Figure 3-7).   
 
Figure 3-7. Specific activity of unlabeled PI-PLC variants with 4 mM PI and increasing 
concentrations of PC: (1) WT* (2) Y86A* (3) Y88A* (4) Y86A/Y88A* (5) Y246A* (6) Y247A* 
(7) Y246A/Y247A* (8) Y204S* (9) Y248A* and (10) Y204S/Y248A*. All of these PI-PLC 
variants contain the N168C mutation used for fluorophore attachment. 
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    None of the mutations significantly inhibited the rate of PI cleavage in vesicles. 
Enzyme activity is low towards pure PI SUVs and increases significantly once PC is 
present. The decrease in specific activity at 80% PC has been observed for WT and other 
PI-PLC variants [13] and has been suggested to arise from protein sequestration from 
substrate in PC-rich vesicles (one can think of this as being below a 2-D Km measured in 
mole fraction of substrate, here XPI = 0.2) [17]. Although this ‘surface dilution inhibition’ 
occurs for all the tyrosine variants, the actual extent of loss of activity compared to the 
maximum activity (at XPC = 0.5) varied suggesting that weakening vesicle binding at high 
XPC increases the probability that either (i) substrate can more easily access the enzyme 
active site (perhaps high PC clusters around the protein preventing PI access) or (ii) the 
enzyme can dissociate from one vesicle and land on another more easily. 
3.7 Two classes of Tyr in BtPI-PLC involved in cation-π interactions. 
    The energetics of Tyr/PC cation-π interactions can be estimated by calculating ΔΔG, 
the loss in binding energy caused by the mutation, from comparing the apparent Kd for a 
given Tyr mutant to WT: 
ΔΔG = RT ln {K(mut)/K(WT)}     where T = 295 K . 
Comparing the ΔΔG calculated from the apparent Kd values (Table 3-2) can also provide 
qualitative information about the type of interaction between tyrosines and PC. The 
tyrosine mutants fall into two classes: (i) those where Kd(mut)/Kd(WT) < 5 (Y86A*, 
Y247A*) and (ii) those where the ratio of mutant Kd to that of the WT was greater than 
50  (Y88A*, Y204S*, Y246A*, Y248A*, Y251A*). The free energy change associated 
with Tyr86 and Tyr247 is approximately -1 kcal/mol. This value is comparable to that 
predicted by the Wimley-White scale (0.94±0.06 kcal/mol for the transfer of tyrosines 
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from water to POPC) and in the range of a hydrogen bonded interaction. It is also close to 
the Wimley-White scale for Tyr transfering to octanol (-0.71±0.11 kcal/mol), which 
reflects hydrophobic interactions. In contrast, removal of tyrosines 88, 204, 246 or 251 is 
linked to a higher energy cost: 2.5±0.2 kcal/mol, towards pure PC vesicles. These higher 
energies would be the values associated with PC cation – Tyr-π interactions. Removal of 
Ty248 has the highest energy cost of the single Tyr mutants: 3.0±0.1 kcal/mol, consistent 
with its hydrophobic interactions and role in stabilizing the β6-αG loop structure. An 
estimated upper limit of −3.6 kcal/mol for formation of a methylammonium-benzene 
cation-π interaction has been reported [18]. Altogether, these results strongly indicate the 
presence of these cation-π interactions between BtPI-PLC and PC stabilizing the binding 
of this amphitropic protein to membranes. 
 
Table 3-2. Kd and ΔΔG values for Tyr ! Ala mutants of BtPI-PLC. 
 
 
 
 
 
 
 
 
 
 
 
Mutation Kd  (mM) Kd(mut)/Kd(WT) ΔΔG (kcal/mol) 
   WT    0.016±0.003   
Y86A*    0.072±0.005           4.5      0.88±0.04 
Y88A*    1.2±0.1         75      2.53±0.05 
Y204A*    0.87±0.58         54      2.3±0.5 
Y246A*    1.2±0.3         75      2.5±0.2 
Y247A*    0.082±0.007           5.1      0.96±0.05 
Y248A*    2.5±0.5       156      3.0±0.1 
Y251A*    0.81±0.41         51      2.3±0.3 
Y86A/Y88A*    1.1±0.4         69      2.5±0.2 
Y246A/Y247A*    2.0±0.1       125      2.83±0.03 
Y248A/Y204A*  11±3       688      3.8±0.2 
Y204A/251A* 
 
   2.8±2.1       175      3.0±0.6 
! 66!
3.8 Conclusion 
    The binding affinity between amphitropic proteins and the membrane lipids is typically 
the result of reversible interfacial interactions, most often referred to as the sum of 
electrostatics between basic amino acids (Lys, Arg) and the negative charged polar head 
group region of phospholipid, and hydrophobic interactions of aliphatic amino acids with 
the lipid tails. The role of interfacial aromatic amino acids is seldom mentioned despite 
the importance of these residues. Our results suggest that tyrosine residues are involved 
in interfacial cation-π interactions. The cation-π interactions are energetically equivalent 
to or stronger than hydrophobic interactions or electrostatic interactions. Cation-π 
interactions are thought to be less sensitive to the solvent dielectric constant than salt 
bridges [18], making them well-adapted for the interface between a low dielectric 
environment and a high dielectric environment. Our results suggest that overlooked 
cation-π interactions between membranes and aromatic amino acids of amphitropic 
proteins may play an important role not only in membrane binding but also in lipid 
recognition. 
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Chapter 4 
Distinguishing cation-π interactions from simple 
insertion of an aromatic side chain into a membrane – 
SaPI-PLC 
!!!!!!!!
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4.1 Introduction 
    Peripheral membrane proteins can be targeted to membrane via interactions with 
specific phospholipids (e.g., phosphatidylserine [1], phosphoinositides [2,3], phosphatidic 
acid [4]). Although phosphatidylcholine (PC), a major component of eukaryotic 
membranes, is usually considered a structural lipid, it can also serve as a specific anchor 
for amphitropic proteins. As an example, the extracellular B. thuringiensis PI-PLC binds 
poorly to vesicles of anionic phospholipids, but with increasing avidity to vesicles 
containing PC. The targets of this enzyme are GPI-anchored proteins in the external 
leaflet of the plasma membrane, and affinity for PC would aid in directing the enzyme to 
its mammalian cell target. As discussed in Chapter 3, mutagenesis, NMR, and MD 
simulations are consistent with choline cation / tyrosine π complexes providing a 
significant amount of the binding energy for BtPI-PLC. However, none of these 
experiments absolutely distinguishes nonspecific side-chain insertion from very specific 
formation of a cation-π complex with PC. Alanine substitution of tyrosines produces a 
large change in the side chain volume and cannot identify the source of lost binding 
affinity. The NMR experiments localized long-lived PC binding sites, but could not 
define the complex explicitly as a cation-π complex. The MD simulations suggest such 
complexes can occur but many are transient in nature. Clearly, a more direct 
experimental method is needed to prove the existence of such interactions. 
    We have developed a method to separate the two membrane binding modes which uses 
site-specific incorporation of fluorinated amino acids, in this case 
pentafluorophenylalanine (F-F5) and 3,5-difluorotyrosine (Y-F2). The fluorinated amino 
acids are more hydrophobic [5] and are therefore likely to enhance binding by insertion. 
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However, the altered electrostatics of the fluorinated aromatic ring should destabilize 
cation-π interactions [6].  
4.2 SaPI-PLC Model System 
    The method alluded to section 4.1 is first tested with the related Staphylococcus aureus 
PI-PLC, which has little affinity for PC and binds preferentially to membranes rich in 
anionic phospholipids [7,8]. However, the introduction of two tyrosines, at Asn-254 and 
His-258 (N254Y/H258Y), to mimic the Bacillus enzyme, leads to choline binding 
specificity, presumably due to cation-π complexes since a crystal structure (PDB: 4I90) 
exists of N254Y/H258Y with two choline bound [9] (Figure 4-1). Site 1 uses Tyr212 and 
H258Y to form the cation-π site for the choline trimethylammonium group (Figure 4-1). 
It requires a large rotation of the Tyr211 side chain to form the binding site. Choline in 
site 2 makes similar cation-π interactions with Trp287 and Tyr290. The rotation of 
H258Y forms the right side of binding pocket 1, as well as the left side of binding pocket 
2. A crystal of N254Y/H258Y soaked with dibutyroyl-PC (diC4PC) showed only site 2 
occupied by the PC choline moiety (Figure 4-2) and the quaternary amines of the choline 
and diC4PC ligand are completely superimposable, strongly suggesting that this is the site 
for the PC choline when the protein docks to membranes. Tyr258 in particular appears 
critical for choline binding, either by direct interaction or by aligning other aromatic 
residues.  
    In contrast to tyrosine residues thought to be involved in specific choline binding, a 
phenylalanine (Phe249) in a surface loop around the active site is thought to contribute to 
binding by inserting into the membrane [7,8](Figure 4-3). With this in mind, introducing 
a fluorinated Tyr at residue 258 would weaken the protein binding to PC-rich vesicles 
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(since Tyr258 contributes to choline cation/Tyr π interactions) while a fluorinated Phe at 
249 would enhance vesicle binding for all vesicle compositions. 
Figure 4-1. Overlay of the SaPI-PLC N254Y/H258Y structure without choline (dark blue, PDB 
4I8Y) and with choline bound (pale cyan, PDB 4I90) showing that choline site 2 (orange) is 
preformed, whereas site 1 (yellow) requires rotamer changes in side chains.  
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Figure 4-2. Overlay of the SaPI-PLC N254Y/H258Y structure without diC4PC (dark blue, PDB 
4I8Y) and with diC4PC bound (pale cyan, PDB 4I9J) showing the lipid in site 2 (orange). 
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Figure 4-3 Overlay of the acidic pH (magenta, PDB 3V16) and basic pH (cyan, PDB 3V18) 
structures of SaPI-PLC. The red circle highlights the mobile rim loop and the large 
conformational change in it with pH. Phe249 and His258 are labeled. myo-Inositol is depicted in 
red space-filling representation. A gray bar represents the membrane interface. 
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4.3 Fluorinated amino acid incorporation strategy 
    F-F5 was incorporated at residue 249 and 258 to make single mutant F249F-F5 and 
H258F-F5, Y-F2 was incorporated at residue 258 to make variant N254Y/H258Y-F2. By 
comparing the binding affinity and enzyme specific activity of fluorinated protein to the 
control (F249F-F5 to WT, H258F-F5 to H258F, N254Y/H258Y-F2 to N254Y/H258Y), we 
directly assess if the specific residue was involved in cation-π interations or membrane 
insertion. 
4.4 Secondary structure of fluorinated protein variants 
    F-F5 and Y-F2 were prepared as previously described in Chapter 2, section 2.2. F249F-
F5, H258F-F5 and N254Y/H258Y-F2 were constructed, expressed and purified as 
described in Chapter 2, section 2.3, with WT, H258F and N254Y/H258Y purified and 
used as control, respectively. The fluorinated SaPI-PLC yield was 4-6 mg/L, compared to 
the 60mg/L yield of native protein.  
    Secondary structure and thermal stability of the above SaPI-PLC variants were 
measured and all variants were well folded with similar CD spectra (Figure 4-4) and 
secondary structure (Table 4-1). However, the fluorinated variants showed slightly less 
thermal stability compared to their native controls. Since the proteins irreversibly 
denature in these experiments, this small difference could reflect increased 
hydrophobicity of the fluorinated variants. Overall, the CD experiments indicate that the 
F-F5 or Y-F2 substitutions are tolerated well by the protein. 
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Table 4-1. Analysis of PI-PLC secondary structure and thermostability of S. aureus PI-PLC and 
its variants. 
 
Variant α-helix 
(%) 
β-sheet (%) β-turn (%) Random (%) Tm (oC) 
WT 18.2 33.9 16.6 31.3 64 
F249F-F5 20.1 31.1 16.9 31.9 61 
H258F 18.2 33.9 16.8 31.1 62 
H258F-F5 20.3 29.0 16.5 34.2 61 
N254Y/H258Y 18.0 33.9 16.5 31.6 63 
N254Y/H258Y-F2 18.4 32.5 16.5 32.6 60 
 
 
Figure 4-4. Comparison of CD spectra for WT (!) and N254Y/N254Y-F2 (").  
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4.5 Analysis of the incorporation of F-F5 and Y-F2 into S. aureus PI-PLC 
    ESI-TOF MS analysis was used to show that the fluorinated amino acids were 
incorporated into S. aureus PI-PLC F249F-F5 and H258F-F5. F249F-F5 gave an observed 
average mass of 36,807 Da and H258F-F5 an average mass of 36,819, while WT has an 
observed mass of 36,719 (Figure 4-5). These results were in agreement with the 
calculated mass. MS/MS analysis of the collision-induced dissociation (CID) also 
confirmed the fluorinated modification at these desired sites. Figure 4-5B shows peptide 
fragments of the protein with the fluorinated residue. Thus, the ESI-MS and MS/MS 
together confirmed successful incorporation of F-F5 at site 249 and 258.  
    Mutant N254Y/H258Y-F2 showed a high avidity for salts. This in turn precluded 
successful analysis by ESI-TOF. Instead, the protein containing Y-F2 was trypsinized and 
the mixture examined for fluorinated peptides to determine the site of fluoro-compound 
incorporation. Figure 4-5C show the ions corresponding to fragments of the tryptic 
peptide containing Y-F2 at residue 258 in S. aureus PI-PLC. Lists of the MS/MS 
fragments detected for both N254Y/H258Y-F2 and H258F-F5 are provided in Tables 4-2 
and 4-3. 
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Figure 4-5. MS confirmation of fluorinated amino acid incorporation in S. aureus PI-PLC. (A) 
Intact MS analysis of wildtype, F249F-F5 and H258F-F5 proteins. (B) MS/MS and collision-
induced dissociation analysis of S. aureus PI-PLC, F249F-F5 and H258F-F5. (C) MS/MS 
identification of the tryptic peptide fragments containing the fluorinated tyrosine in 
N254Y/H258Y-F2. Red and blue indicate the b (N-terminal) and y (C-terminal) ions, 
respectively. 
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Table 4-2. MS/MS fragments of the tryptic peptide containing the N254Y/H258Y-F2 mutation 
with intensities >900. The full peptide sequence is 226AKTDS NKDNVYVNFL SVASGGSAFN 
STYYYAS Y-F 2IN PEIAK265 and the MS/MS data, including all identified peptides, are shown 
in Figure 4-5C. 
 
 
C-term 
Fragment 
Fragment Sequence Predicted 
Mass (Da) 
Measured Mass 
(Da) 
y6+ 260N PEIAK265 671.37 671.60 
y7+ 259IN PEIAK265 784.46 784.60 
y8+ 258 Y–F2 IN PEIAK265 983.50 983.60 
y9+ 257SY-F2IN PEIAK265 1070.53 1070.73 
y10+ 256AS Y-F2IN PEIAK265 1141.57 1141.87 
y11+ 255YASY-F2IN PEIAK265 1304.63 1304.87 
y12+ 254YYASY-F2IN PEIAK265 1467.70 1467.87 
y213+ 245GGSAFN STYYYASY-F2IN PEIAK265 784.69 784.60 
y242+ 242VASGGSAFN STYYYASY-F2IN PEIAK265 1305.10 1304.87 
y273+ 239FLSVASGGSAFNSTYYYASY-F2IN PEIAK265 986.13 985.80 
N-term 
Fragment 
   
b182+ 226AKTDS NKDNVYVNFL SVA242 983.99 983.93 
b282+ 
226AKTDSNKDNVYVNFLSVASGGSAFN 
STY253 1469.69 1469.80 
b313+ 
226AKTDS NKDNVYVNFL SVASGGSAFN 
STYYYA256 1112.52 1112.20 
b323+ 
226AKTDS NKDNVYVNFL SVASGGSAFN 
STYYYAS257 1141.53 1141.87 b333+! 226AKTDS!NKDNVYVNFL!SVASGGSAFN!STYYYAS"Y#F2258! 1207.88! 1208.27!b383+! 226AKTDS!NKDNVYVNFL!SVASGGSAFNSTYY"YAS!Y#F2IN!PEI263! 1396.64! 1396.87!
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Table 4-3. MS/MS fragments of the tryptic peptide containing the H258F-F5 mutation. The full 
peptide sequence is 226AKTDS NKDNVYVNFL SVASGGSAFN STYNYASF-F5IN PEIAK265 
and the MS/MS data are shown in Figure 4-5. 
 
 
C-term 
Fragment 
Fragment Sequence Predicted 
Mass (Da) 
Measured 
Mass (Da) 
y5- 261PEIAK265 557.33 557.33 
y6- 260N PEIAK265 671.37 671.40 
y7- 259IN PEIAK265 784.46 784.47 
y8- 258F-F5IN PEIAK265 1021.48 1021.47 
y9- 257SF-F5IN PEIAK265 1108.51 1108.60 
y10- 256ASF-F5IN PEIAK265 1179.55 1179.60 
y11- 255YASF-F5IN PEIAK265 1342.61 1342.60 
y12- 254NYASF-F5IN PEIAK265 1456.65 1456.60 
y13- 253YNYASF-F5IN PEIAK265 1619.72 1619.73 
y15- 251STYNYASF-F5IN PEIAK265 1807.80 1807.40 
y16- 250N STYNYASF-F5IN PEIAK265 1921.84 1921.40 
 
     19F NMR was also used to establish incorporation of the fluorinated amino acid. Both 
F249F-F5 and N254Y/H258Y-F2 in solution exhibited an asymmetric and fairly broad 
pattern consistent with restricted motion of the fluorinated amino acid side chain on the 
34 kDa protein (and also enhanced aggregation at the concentration of protein, 7 mg/mL, 
used for the solution 19F NMR experiments). In 2% SDS, protein exhibited a 
considerably narrower spectrum (Figure 4-6), although there is still evidence of slower 
motion and for N254Y/H258Y-F2 the two 19F on the tyrosine ring have different 
environments in the SDS micelles. These spectra indicate that Y-F2 and F-F5 have been 
incorporated into S. aureus PI-PLC.  
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Figure 4-6. 19F-NMR spectra (600MHz) confirm the incorporation of fluorinated amino acid in 
SaPI-PLCs. (A) Y-F2; (B) N254Y/H258Y-F2 in 2% SDS, Tris pH 8.5; (C) native N254Y/H258Y-
F2 in Tris pH8.5; (D) F-F5; (E) F249F-F5 in 2% SDS, Tris pH 8.5. Both protein concentrations 
were 7 mg/ml (0.2 mM). 
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4.6 Crystallography and comparison of structures 
    F249F-F5 and H258F-F5 crystals were grown and data collected as described in 
Chapter 2, section 2.11 (Table 4-4). Replacement of Phe with the fluorinated analog F-F5 
should destabilize cation-π interactions. To test this, we took advantage of the 
observation that an intramolecular cation-π interaction between Phe249 and His258 is 
seen for the WT protein when crystallized under acidic conditions. The structure of 
F249F-F5 was solved and compared to the structure for WT obtained under acidic pH 
conditions. Electron density is contoured to 1σ for the aromatic residues near the 
mutation in Figure 4-7A to show the quality of the data. The cation-π interaction between 
Phe249 and the cationic His258 has a planar stacking distance of 3.5 to 4.3 Å between the 
aromatic rings [7]. With the F-F5 introduced at position 249, the cation-π complex can no 
longer form (Figure 4-7C), and F249F-F5 adopts a conformation similar to that of the WT 
structure crystallized at basic pH [7]. However, the mobile loop preceding helix G is in a 
different orientation. This feature of the structure, variable in many of the S. aureus 
mutant crystal structures [7,8,9], is near protein contacts in the crystal. The specific 
orientation of the loop for F249F-F5 likely aids in stabilizing the more hydrophobic F-F5 
side chain in the crystal (Figure 4-8). 
    H258F-F5 was also crystallized under acidic conditions; Figure 4-7B provides an 
example of the electron density. Since His258 has been replaced, the intramolecular 
cation-π interaction cannot form. In this variant, the loop with Phe249 adopts a 
conformation close to that seen for H258Y [7] (Figure 4-7D). More importantly, the Tyr 
at residue 258 is nearly superimposable with the F-F5 indicating that introduction of the 
fluorinated amino acid had virtually no effect on helix G. These structures show that the 
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electrostatics of the fluorinated Phe preclude formation of cation–π complexes but 
otherwise have little effect on the overall structure. 
 
Table 4-4. Full refinement and model statistics for F249F-F5 and H258F-F5 structures. 
 
 
 
a Rwork = {∑||Fo| − |Fc)/|Fo|}, where |Fo| and |Fc| are the observed and calculated structure 
factor amplitudes, respectively.   
b Rfree is calculated from a set of 5% randomly-selected reflections that were excluded 
from the refinement.  
 
 
 
 
F249F-F5 
(PDB 4S3G) 
H258F-F5 
(PDB 4RV3) 
diffraction data 
 
resolution range (Å) 42.26-2.5 49.87-2.0 
no. of reflections  12823 22307 
no. of reflections in free set 623 1139 
space group P43212 P43212 
unit cell 
a (Å) 60.05 59.85 
b (Å) 60.05 59.85 
c (Å) 191.33 180.41 
completeness 99.7 96.6 
Rmerge 0.053 0.056 
refinement 
 
Rcrysta 0.212 0.180 
Rfreeb 0.291 0.238 
no. of residues 301 302 
no. of non-hydrogen protein atoms 2408 2433 
no. of H2O molecules 54 161 
no. of non-hydrogen inositol atoms 12 12 
no. of ions 1 1 
rmsd bonds (Å) 0.010 0.007 
rmsd angles (deg) 1.337 1.020 
ave B-factor (Å2) 49.0 29.0 
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Figure 4-7. Representative electron densities of (A) part of the rim loop in the mutant F249F-F5 
and (B) part of the helix G in the mutant H258F-F5 structures, shown in grey and contoured at 1σ.  
Overlay of the pH 4.6 structures for (C) WT (yellow, PDB: 3V16) and F249F-F5 (red, PDB: 
4S3G), (D) H258Y (magenta, PDB: 3V1H) and H258F-F5 (cyan, PDB: 4RV3) S. aureus PI-PLC. 
Key residues are labeled. myo-Inositol is depicted in space-filling representation. 
 
Figure 4-8. Crystal packing for WT (3V16) and mutant F249F-F5 (4S3G) PI-PLC. The rim loop 
region containing residue Phe-249 or Phe-F-F5 is circled in magenta and indicated with arrows in 
respective unit cell. This shows that the hydrophobic residue in the rim loop affects the packing of 
monomers in the crystal. 
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4.7 S. aureus fluorinated PI-PLC binding to vesicles 
    Binding of S. aureus PI-PLC proteins to PG/PC SUVs was monitored by FCS at a pH 
of 6.5, the pH optimum of the enzyme. WT protein has weak affinity for PC as shown in 
Figure 4-9A (open circles). The apparent Kd decreases substantially as XPC increases. 
Phe249 has been postulated to insert into membranes and its replacement with alanine 
weakens binding [7]. Replacing that aromatic residue with F-F5 enhances binding across 
the vesicle composition (Figure 4-9A, filled circles). The enhanced binding affinity is 
shown in Figure 4-9D where the ratio of Kd for F249F-F5 is compared to the WT Kd. The 
increased affinity of F249F-F5 for all vesicles correlates with better partitioning of the 
more hydrophobic F-F5 into the bilayer.  
    The affinity of H258F for the SUVs is comparable to WT protein (within a factor of 
two across the range of compositions). The binding of H258F-F5 compared to H258Y 
(Figure 4-9B) is similar for XPC <0.5. However, at high XPC H258F-F5 binding is five-
fold weaker than H258F. Not enough binding of H258F-F5 was measured at XPC = 0.9 to 
generate a Kd. In this case, although WT has low affinity for PC-rich membranes, its 
affinity is further reduced with incorporation of F-F5. Since structurally H258F-F5 is very 
similar to H258Y, the loss of affinity at high XPC might suggest that in H258F there is 
some tendency for that Phe to interact with choline headgroups. Formation of such a 
complex would be weak, requiring significant PC in the bilayer. 
    N254Y/H258Y, as reported previously, shows a dramatic increase in affinity for PC-
rich SUVs indicative of the introduction of a PC-site with these mutations [9]. As the PC 
content increases above XPC=0.5, tight binding of N254Y/H258Y is observed (Figure 4-
9C). The shape of the curve is consistent with a PC cation / Tyr-π interaction contributing 
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to binding in the PC-rich region and electrostatic interactions dominating binding in PG-
rich vesicles. Rather than introduce F-F5 at this position we chose to incorporate Y-F2. 
However, substituting Y-F2 for a surface tyrosine can also alter the electrostatic 
distribution, because the Y-F2 hydroxyl pKa is shifted to around 7.5 [10]. Since S. aureus 
PI-PLC is optimally acidic at pH 6.5, and the binding was measured at that pH, 
deprotonation of the hydroxyl should not dominate the binding. For the most anionic 
SUVs, where introduction of a negative charge on the protein should have the strongest 
effect on binding (XPC = 0 and 0.2), the Kd for N254Y/H258Y-F2 is the same as that for 
N254Y/H258Y (Figure 4-9C). As SUVs become enriched in PC, N254Y/H258Y-F2 loses 
much of the binding affinity compared to N254Y/H258Y. This is easily seen in Figure 4-
9D where the ratio of Kd for N254Y/H258Y-F2 is compared to its control N254Y/H258Y. 
From the ratio of Kd for the fluorinated enzyme compared to its control, we can estimate 
the free energy lost with incorporation of the Y-F2. At XPC = 0.65, 0.8 and 0.9, ΔΔG 
values are +1.46, +1.36 and +1.82 kcal/mol, respectively. This very dramatic loss of 
affinity is consistent with the role of Tyr258 in cation-π complexes with choline 
headgroups [9].  
    Interestingly, for pure PC SUVs, ΔΔG is +0.65 kcal/mol when the Tyr is fluorinated. 
The lower ΔΔG and the fact that N254Y/H258Y-F2 binding could still be measured 
towards pure PC vesicles might suggest that the cation-π interaction has been weakened 
but still forms to some extent. Perhaps this is not surprising since only two F atoms were 
incorporated into the ring. However, another interpretation is that the large ΔΔG values 
for N254Y/H258Y-F2 binding to SUVs with some PG indicate that the cation-π complex 
requires PG binding in the active site for optimal formation. 
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Figure 4-9. Apparent dissociation constants for S. aureus PI-PLC variants with fluorinated 
aromatic amino acids binding to PG/PC SUVs as a function of mole fraction PC: (A) F249F-F5 
(●) compared to WT (❍);  (B) H258F-F5 (▲) compared to H258F (Δ); and (C) N254Y/H258Y-
F2 (■) compared to N254Y/H258Y (❒). In  (D) is shown the ratio of the Kd for the fluorinated 
protein to the Kd of its control as a function of XPC; symbols are the same as in A through C. 
 
 
 
 
 
4.8 Enzyme activity of fluorinated SaPI-PLC 
    With the exception of the pure PI SUVs, enzymatic activities for all the S. aureus PI-
PLC variants were carried out under conditions where the total amount of phospholipid is 
significantly above the apparent Kd measured by FCS for PG/PC SUVs. Thus, nearly all 
the proteins should be partitioned on the vesicles. Specific activities all increase with 
increasing PC content (Figure 4-10). For WT this is not due to a specific PC interaction 
with the protein but rather because the zwitterionic species reduces the surface PI (PG, or 
PA as well) concentration and prevents the anionic lipid from binding to an cationic site 
adjacent to the active site that antagonizes dimerization [8]. Therefore, all mutants 
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exhibited higher activities with increasing XPC. However, superimposed on that behavior 
were some interesting trends. F249F-F5 had higher activity than WT towards PI in 
vesicles with XPC < 0.5, while H258F-F5 had lower specific activity than H258F. 
N254Y/H258Y-F2 had lower activity than its control, N254Y/H258Y, at all XPC. The 
increased activity for F249F-F5 correlates with increasing the hydrophobicity of a side 
chain that partitions into the membrane. 
    These differences in specific activities under conditions where the proteins are bound 
to the vesicles indicate that PC cation – protein π interactions, while they do contribute to 
bulk binding, must also enhance either substrate access or hydrophobic product exit from 
the active site of the anchored protein.  
Figure 4-10. Specific activities of S. aureus PI-PLC mutants towards PI/PC SUVs as a function 
of mole fraction PC (XPC): WT (■), F249F-F5 (///), H258F (■), H258F-F5 (:::), N254Y/H258Y 
(❒), and N254Y/H258Y-F2 (\\\\). PI was fixed at 4 mM with increasing amounts of PC. Protein 
concentrations were adjusted to 0.3-4 µg/ml to ensure less than 20% cleavage of the PI (4 mM). 
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4.9 Conclusion 
    The incorporation of fluorinated amino acids into the S. aureus PI-PLC has allowed us 
to assess directly the specific interaction mode of aromatic residues with membranes. The 
loss of binding affinity correlates with F-F5 or Y-F2 indicates participation in a choline 
caton – aromatic π interaction. Enhanced vesicle binding correlates with better 
partitioning of a side chain into the target bilayer. For this particular enzyme the results 
also suggest that Phe249 nonspecific insertion into the membrane and cation-π complexes 
with Tyr258 are not only relevant to bulk partitioning of the enzyme on surfaces but to 
how a given phospholipid substrate reaches the active site.  
    Since crystal structures of the S. aureus PI-PLC exist with choline and dibutyroyl-PC, 
we had evidence for the role of Phe249 and Tyr258 in nonspecific and specific, 
respectively, interactions with membranes. Thus, the incorporation of F-F5 and Y-F2 
served as a proof of principle for the method. The success clearly shows that this 
approach should be useful in providing a direct test of predictions from MD simulations 
and in designing membrane binding interfaces based on PC cation – protein π 
interactions.  
    Integral membrane proteins have aromatic residues at the membrane surface and these 
may also engage in cation–π interactions with the membrane. For example, PC 
modulation of an aspartate transporter from Pyrococcus horikoshii  is postulated to occur 
through a cation-π interaction with a surface Tyr and the lipid headgroup. In that case, the 
interaction influences conformational flexibility of the oligomerization domain which in 
turn modulates the rate of transport [11]. Use of Y-F2 in such a system could provide 
direct evidence for such as cation-π interaction.  
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Chapter 5 
Identifying which Tyr in BtPI-PLC form cation-π 
complexes with PC 
!!!!!!!!!!
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5.1 Introduction 
    Given the success in using fluorinated aromatic amino acid incorporation to distinguish 
aromatic side chain partitioning into a bilayer from PC cation-π interactions, we 
examined the PI-PLC from B. thuringiensis. MD simulations suggested the tyrosine 
residues on BtPI-PLC surface and choline headgroups form short-lived cation-π 
interactions at the protein-membrane interface. Our mutagenesis study by changing Tyr 
to Ala suggested that the tyrosines involved in membrane binding fell into two different 
categories: (i) removal of tyrosines at positions 86 and 247 was associated with 1 
kcal/mol (4.2 kJ/mol) energy cost while removal of tyrosines at positions 204, 246, 247, 
248 and 251 was associated with 2.5±0.2 kcal/mol (10.5±0.8 kJ/mol) energy cost. As we 
know aromatic residues could also form hydrophobic interactions with membrane lipids, 
and replacing a Tyr with a smaller Ala would also show a binding defect if the Tyr was 
partitioning into the bilayer. This being said, are the above energy costs caused by loss of 
specific cation-π interactions or nonspecific side-chain portioning into the membrane? Is 
there a direct way to tell if these are cation-π interactions? 
    In this chapter, I describe a further application of fluorinated amino acid incorporation 
to differentiate cation-π interations from membrane insertion. Instead of changing Tyr ! 
Ala, We constructed seven Y-F2 variants (Y86Y-F2, Y88Y-F2, Y204Y-F2, Y246Y-F2, 
Y247Y-F2, Y248Y-F2 and Y251Y-F2) and examined their binding to PG and PC SUVs at 
pH 7.4, the optimal pH for enzyme activity. At that pH the hydroxyl group of each 
surface Y-F2 will be around 50% ionized introducing a partial negative charge in the 
vicinity of the bilayer. That is likely to affect affinity of the proteins for PG surfaces 
(quantified by the Kd for pure PG SUVs) but have a modest effect on binding to a 
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zwitterionic bilayer (pure PC SUVs). For the latter, a reduction in the Kd value would 
indicate nonspecific partitioning of that Tyr into the bilayer, while an increase in Kd 
would indicate lost participation of that Tyr in PC cation-π binding.  
5.2 Cloning, purification and characterization of BtPI-PLC 
    The original BtPI-PLC plasmid was cloned into a pET23b vector to add a C-teriminal 
His tag to the BtPI-PLC protein, as described in Chapter 2, section 2.3. This was added to 
simplify the purification process and decrease the protein loss during purification steps. 
The non-tagged protein was purified by an anion exchange column followed by a 
hydrophobic column, which was not suitable for Y-F2 incorporated proteins with 
increased hydrophobicity.  The overexpression and purification of fluorinated BtPI-PLC 
was also described in Chapter 2, section 2.3. Protein yield was only 1-2 mg/L, compared 
to the 40 mg/L yield of native BtPI-PLC. A large drop in the yield of purified SaPI-PLC 
was also observed upon fluorinated amino acid incorporation. 
Figure 5-1. SDS-PAGE of purified His-tagged BtPI-PLC Y246Y-F2 fractions. 
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    The purified BtPI-PLC variants were subjected to 19F NMR (600MHz) analysis to 
confirm the success incorporation of Y-F2. All of the variants showed similar 19F broad 
spectra (Figure 5-2) with powder pattern characteristics (three ‘peaks’ that actual reflect a 
19F tensor describing the chemical shift environment for the two fluorine nuclei). This 
suggests significant aggregation of the fluorinated proteins. As such the native protein 19F 
spectra are difficult to interpret. Denaturation of proteins should at least indicate the 
presence of the fluorinated amino acid (since the sharper free amino acid would appear as 
a spike on these broader patterns). In 2% SDS, protein exhibited a narrower spectrum, 
although an asymmetric pattern still exists. This reflects either (i) the two fluorines on the 
tyrosine ring still have different environments in the SDS micelles or (ii) the micelles 
with the protein are still large enough to not average the dipolar pattern. These spectra 
indicate that Y-F2 has been incorporated into each of the BtPI-PLC mutants. 
Figure 5-2. 19F spectra of Y-F2 molecule (top), Y246Y-F2 in 2% SDS (middle) and native 
Y246Y-F2 (bottom). All other variants have similar patterns. 
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5.3 Fluorinated BtPI-PLC binding to vesicles 
    Binding of BtPI-PLC to vesicle surfaces (measured with FCS) reflects the first step in 
enzyme activity. All Y-Y2 variants show impaired binding to PG SUVs, the apparent Kd 
increasing from 5.6 mM for WT to 30-40 mM (Table 5-1). The average ΔΔG for the 
effect of incorporation of Y-F2 in these proteins is +1.05±0.12 kJ/mol in binding energy. 
That positive ΔΔG represents the electrostatic cost of placing a fluorinated ring (and 
partial negative charge) of the protein at an anionic interface.  
 
Table 5-1. Apparent Kd value for BtPI-PLC Y!Y-F2 mutants and extrapolated ΔΔG for loss of 
binding. 
 
PI-PLC PG SUVs 
Kd (mM) 
ΔΔG  
(kcal/mol) 
(PG) a 
PC SUVs 
Kd (mM) 
ΔΔG 
(kcal/mol) 
(PC) a 
% 
occupancy  
cation-π b 
PC SUVS, Kd  
for YnnnAb 
(mM) 
WT 5.60±0.04  0.030±0.006    
Y86Y-F2 41.2±1.2 1.17 0.62±0.03 1.77 22 0.072±0.005 
Y88Y-F2 30.3±1.5 0.86 0.78±0.07 1.60 96 1.2±0.3 
Y204Y-F2 36.9±5.5 1.12 1.04±0.06 2.08 26 0.87±0.58 
Y246Y-F2 34.5±10.1 1.08 1.09±0.02 2.10 77 1.2±0.3 
Y247Y-F2 28.2±1.4 0.96 0.053±0.004 0.33            8.9 0.082±0.007 
Y248Y-F2 40.2±9.4 1.17 2.31±0.07      2.53            1.9 2.5±0.5 
Y251Y-F2 28.7±8.6 0.96 0.69±0.46 1.84 36 0.8±0.4 
 
a Extrapolated from the ratio of Kd(mutant)/Kd(WT) at 22 oC. 
b From Chapter 2. 
 
    In contrast to the uniform behavior of these variants with a PG vesicle, the Kd values 
for pure PC SUVs covered a much wider range. The Y247Y-F2 Kd was less than two-fold 
higher than WT and indicated it is not contributing significantly to cation-π interactions. 
The largest increase was for Y248Y-F2 (from 0.03 to 2.3 mM). However, the MD 
simulations suggest this is not because of cation-π interactions but destabilization of the 
loop conformation that positions W242 in the membrane [1]. Y204Y-F2 and Y246Y-F2 
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show the next largest increases in Kd, followed by Y86Y-F2, Y88Y-F2 and Y251Y-F2 
(Figure 5-3). All of these contribute cation-π interactions in the simulations but with 
different occupancies. The important observation is that none of the Kd values for Y-F2 
variants decreased with PC SUVs. Therefore, for this PI-PLC, the surface tyrosines do 
not partition into the membrane but can engage in cation-π interactions to different 
degrees.  
 
Figure 5-3. Apparent dissociation constants for BtPI-PLC variants with fluorinated aromatic 
amino acids binding to PG/PC SUVs as a function of mole fraction PC: WT (●), Y86X (❍), 
Y88X (❒), Y204X (Δ), Y246X (▲), Y247X (■), Y248X (▼), Y251X (◆). X represents for Y-
F2. The grey line indicates the total phospholipid concentration used in activity assay, 8mM PI 
plus increasing concentrations of PC (Figure 5-5). 
 
 
 
 
 
 
    With the exception of Y86A and Y86Y-F2, the Kd values for the Y-F2 variants also 
correlate well with those for the alanine variants (Table 5-1). For both types of 
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substitutions (Ala or Y-F2), there is a very qualitative correlation of the loss of binding 
affinity with cation-π occupancy observed in the MD simulations (Figure 5-4).  
 
Figure 5-4.  The change in free energy upon binding to vesicles for Tyr ! Ala (blue circle) and 
Tyr ! Y-F2 (red solid circle) mutations in BtPI-PLC as a function of the cation-π occupancy 
extracted from MD similations of the protein binding to pure PC SUVs. 
 
 
    What is particularly interesting in the plot is that it is not linear, which one might 
expect if the Tyr residues contributed to separate complexes with a PC headgroup.  For 
example, the occupancy for Tyr204 is low in the simulation but significant energy is lost 
when it is replaced. A possible explanation is that two Tyr can form a complex with the 
same PC. In the simulation [1], there is a small occupancy of such two Tyr complexes. 
However, in reality these may be much more prevalent over the time scale the protein 
likely residues on a given vesicle (100-400 ms [2]). An alternative explanation is that a 
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lower occupancy Tyr such as Tyr86 is involved in stabilizing a longer-lived cation-π 
complex but not by directly acting as a ligand. Regardless of the explanation, this work 
shows that only Tyr247 does not contribute to PC cation-π interactions that aid in the 
protein binding to membranes. 
5.4 Enzyme activity of fluorinated BtPI-PLC 
    PC is a kinetic activator for BtPI-PLC towards monomer, micelle and vesicle 
substrates [3,4,5]. As shown in Figure 5-5, the specific activities of all the fluorinated 
species increase with increasing PC content.  
 
Figure 5-5. Specific activities of BtPI-PLC mutants towards PI/PC SUVs as a function of mole 
fraction PC (XPC): WT (●), Y86X (❍), Y88X (❒), Y204X (Δ), Y246X (▲), Y247X (■), Y248X 
(▼), Y251X (◆). X stands for Y-F2. PI was fixed at 4 mM with increasing amounts of PC. 
Protein concentrations were adjusted to 0.3-4 µg/ml to ensure less than 20% cleavage of the PI (4 
mM). 
 
 
 
 
 
    All mutants have lower activity towards PI-rich vesicles, which is largely because of 
weaker binding to these vesicles, caused primarily by the partial negative charge of Y-F2. 
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At low XPC = 0.2, only Y247Y-F2 shows a large increase in activity with a small amount 
of PC added. All the other mutants containing Y-F2 show more gradually increasing 
specific activity as the total phospholipid concentration exceeds Kd values. At both XPC = 
0.5 and 0.8 all the protein is vesicle bound, yet there is a substantial increase in specific 
activity for all mutants but Y247Y-F2. Interestingly, Y247Y-F2 specific activity reaches a 
plateau at XPC = 0.2. Once the protein is partitioned onto a vesicle, an individual substrate 
molecule has to partition into the active site. Thus, while Tyr247 does not participate in 
cation-π interactions with PC that aids in bulk binding, the presence of the Y-F2 at that 
site affects binding or positioning of the anionic substrate (or product) in the active site in 
a way that reduces the overall activity of this enzyme. 
    Another interesting difference in fluorinated enzymes versus wild type is the lack of 
‘surface dilution inhibition’ [6]. For BtPI-PLC, the activity toward PI in PC-rich SUVs 
decreases from its maximum around XPC = 0.5. There are many reasons that could 
explain this behavior, (1) An individual PC molecule may have some affinity for the 
active site but only partition into it in at high XPC. (2) In PC-rich vesicles, the mole 
fraction PI is less than the two-dimensional affinity of the protein for PI, measured in 
terms of mole fraction PI, so the protein is not ‘saturated even though it is bound to the 
vesicle surface [7]. (3) PC clusters around the protein preventing PI access into the active 
site. Whatever the reason, the fluorinated proteins are not affected by lowering the mole 
fraction of PI in the substrate vesicle. The fluorinated mutants do have weaker binding to 
PC_rich SUVs than wildtype enzyme, so perhaps PC clustering and excluding PI access 
contributed to the observed surface dilution inhibition of BtPI-PLC. 
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5.5 Conclusion 
    The incorporation of fluorinated amino acids into both SaPI-PLC and BtPI-PLC has 
allowed us to unambiguously assess the specific interaction modes of aromatic residues 
with membranes as either membrane insertion of cation-π interactions.  
    Combining the data in this chapter with MD simulations, mutagenesis studies and 
previous field cycling 31P NMR results, we suggest that Tyr88 and Tyr246 are involved 
in frequent and more persistent cation-π interactions, followed by Tyr86, Tyr204 and 
Tyr251. Tyr247 does not contribute to the cation-π complexes (nor does it partition into 
the membrane). Tyr248 forms intramolecular hydrogen bonds that stabilize the 
orientation of the large interfacial loop and helix G. For PC-rich bilayers, cation-π 
interactions, are ideal for transiently anchoring these protein long enough to search an 
initial area for their GPI-anchored substrates, to cleave ~10 substrates followed by 
hopping to a new region on the PC-rich outer plasma membrane. This type of interaction 
would be necessary since the outer membrane of eukaryotic cells has regions where 
phospholipids and proteins constrained, the former in rafts and the latter via cytoskeletal 
interactions. An extracellular protein cannot simply diffuse around the membrane since it 
is not a homogenous sea of lipids and proteins. Models of the plasma membrane [8] have 
treated the surface as a series of corrals that constrain movements of membrane proteins 
and lipids. Frequent hops of the PI-PLC after a limited 2D-search would be the best way 
to find its target substrates.  
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Chapter 6 
Electrostatic interactions of BtPI-PLC with 
membranes 
!!!!!!!!!!
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6.1 Introduction 
    The association of peripheral membrane proteins with biological membranes is 
classically described as an electrostatically-driven approach followed by the intercalation 
of hydrophobic side groups into the lipid bilayer. Long-range nonspecific electrostatic 
forces between the negatively charged membrane and clusters of basic amino acids are 
thought to bring the protein into a binding-competent orientation relative to the lipid 
bilayer and play a major role for numerous prototypical peripheral membrane proteins [1-
4]. Once the protein is in the vicinity of the membrane, other interactions enhance protein 
binding via more specific contacts (hydrophobic partitioning, hydrogen bonding, or 
cation-π interactions) of key residue side-chains. Experimental and computational 
pioneering studies have evaluated nonspecific electrostatics to contribute a few 
kilocalories per mole to the overall affinity and estimated that each basic amino acid 
contributes up to 1 kcal/mol to the binding free energy [2,5]. 
    BtPI-PLC is a secreted virulence factor that binds specifically to PC-containing 
negatively charged lipid bilayers. The affinity of BtPI-PLC has been measured to be 
tightest for vesicles containing 20% anionic lipids (XPC=0.8). In these conditions, the 
affinity is 4 times more favorable than for neutral vesicles (pure PC) while higher anionic 
lipid content decreases the affinity considerably. Its interfacial binding site consists of a 
small α-helix (helix B) and two neighboring loops rich in tyrosines that we have shown in 
Chapter 3 and Chapter 5 engaged in cation-π interactions with the choline groups of PC 
lipids in membrane bilayers. These cation-π interactions provide a likely molecular 
mechanism for BtPI-PLC PC specificity but do not account for its preference for bilayers 
containing a small fraction of anionic lipids.  
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    The BtPI-PLC interfacial binding site includes five lysines (Lys38, Lys44, Lys122, 
Lys201, Lys279) and one arginine (Arg71). Lys44 on helix B has been previously 
observed to mediate membrane binding by the electrostatic interactions with anionic 
phospholipids [6]. Together with the other four lysines and one arginine, these basic 
amino acids have been identified by MD simulations as aiding in electrostatic interactions 
of the protein to the anionic lipids bilayer.  In this chapter, we combined MD simulations 
and mutagenesis to investigate the electrostatic effect these residues have on membrane 
binding and enzyme activity. Furthermore, by combining electrostatic interactions with 
cation-π interactions, we can formulate a complete model of PI-PLC membrane binding 
using the interplay of these two interactions. 
6.2 MD simulations and mutant design of BtPI-PLC 
    The implicit membrane model simulations MD simulation (done by Dr. Cedric 
Grauffel, University of Bergen, Norway, described in Chapter 3, section 3.2) was used to 
evaluate  the energy contribution for all membrane interacting residues (Figure 6-1B) The 
interactions could be separated into two groups (i) those dominated by hydrophobic 
interactions and (ii) those with electrostatic interactions. This result can be better 
visualized by anchoring the protein into the implicit membrane (Figure 6-1A). Several 
cationic residues (Lys38, Lys44, Lys 201 and Lys 279) were identified by MD simulation 
as aiding in electrostatic interactions of the protein with the anionic lipid bilayer. Lys38 is 
in a loop right before helix B placing it near the rim of the αβ-barrel and above the active 
site. Arg71 is at top of β-strand but away from the membrane binding surface, and this 
arginine as well as Lys44 are conserved in the bacterial PI-PLCs of various species (e.g., 
Staphylococcus aureus, Enterococcus faecalis, Erwinia amylovora). Residues that 
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contributed to the hydrophobic component of binding were Pro42, Ile43, Val46 and 
Trp47 in helix B, which were already studied in our previous work [7]. During the 
interaction with the anionic head group of phospholipids, the electrostatic force is thought 
to orient the protein and thus initiate the binding.  
    Explicit (atomistic) MD simulations with a DMPG bilayer carried out by Hanif M. 
Khan (University of Bergen, Norway) show that BtPI-PLC docked to pure DMPG 
bilayers has much loose binding compared to DMPC-containing bilayers. In one the 
simulations, the protein completely detaches from the bilayer within 200 ns (Figure 6-2). 
In the other simulations, the protein remains bound but the structure of the rim loop 
becomes distorted (Figure 6-3). This simulation result is in agreement with the observed 
weak binding affinity of BtPI-PLC for pure PG vesicles and with the low enzyme activity 
towards pure PI. Simulations with DMPC: DMPG bilayers (XPC=0.5, 0.8, 1) yielded 
stable BtPI-PLC anchorage. Protein regions helix B and rim loop β7-αG anchor the 
protein in bilayer interface (Figure 6-4) at similar depths, and together with the β2-αD 
loop they mediate most of protein with lipid.   
    According to above MD simultions, residues Lys38 (right before helix B), Lys44 
(helix B), Lys279 and Arg71 (on top of β2-αD loop) were mutated to alanine to measure 
their effect on membrane binding and enzymatic activity. According to their positions, 
one would expect Lys44 and Lys38 to have the most effect followed by Lys279 and 
Arg71 the least in contributing to electrostatic binding (we chose not to generate K201A 
since its relative placement with respect to the phospholipid negative charges was 
between Lys38 and Lys279). Meanwhile, V46K was designed to see if an additional 
positive charge could enhance enzymatic activity and vesicle binding. 
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Figure 6-1. MD simulation results shown by structural and energy decomposition models. (A) 
View of the insertion of PI-PLC into the implicit membrane. The limit of the interior region of the 
membrane is represented in brown, and the position of the negative charge in magenta. A color 
gradient going from blue to red is used to describe the residues having respectively a favorable or 
an unfavorable hydrophobic contribution to binding. (B) Plot representing the same energy 
decomposition (in kcal/mol). The Gouy-Chapman terms that account for electrostatic interactions 
are represented with black bars, while boxes represent the hydrophobic contacts. 
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Figure 6-2. Snapshots from one of the MD simulations of WT BtPI-PLC on a DMPG bilayer 
(XPC=0, replica 2). (A) System at the beginning of the production run, (B) system after 200 ns. 
BtPI-PLC is represented by cartoons and the lipids with sticks. helix B (αB, brown), helix D (αD, 
magenta), helix F (αF, cyan), helix G(αG, yellow).  
 
 
 
Figure 6-3. Comparison of the BtPI-PLC membrane bound secondary structure after a 500 ns 
simulation for XPC=0 (red, pure DMPG) and XPC=0.5 (blue). The essential intramolecular 
interactions within the rim loop are lost at XPC=0 causing a distorted loop structure (arrow). 
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Figure 6-4.!BtPI-PLC secondary structure elements and their predicted insertion at the interface 
of a mixed DMPC:DMPG bilayer (XPC= 0.5). The average phosphate plane (brown) is 
constructed from MD simulation data.!
 
 
6.3 Secondary structure of BtPI-PLC variants 
    All alanine variants expressed well and had similar secondary structures and thermal 
stabilities to WT protein indicating that removal of these cationic groups does not affect 
the overall structure of the BtPI-PLC (Table 6-1). 
Table 6-1. Comparison of secondary structure contents and Tm values of WT and mutant BtPI-
PLCs. 
 
Protein α-Helix (%) 
β-Sheet 
(%) 
β-Turn 
(%) 
Random 
Coil (%) Tm (
oC) 
WT 20.6 32.2 17.2 30.0 57.1 
K38A 20.2 32.5 17.1 30.1 57.3 
K44A 21.6 30.9 17.4 30.1 60.3 
R71A 21.4 30.9 17.2 30.3 56.8 
K44A/R71A! 21.9! 30.9! 17.4! 29.8! 58.8!
K279A 20.8 31.8 17.2 30.1 56.0 
V46K 20.7 31.6 17.2 30.6 55.4 
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Interstingly, K44A appeared slightly more stable to thermal unfolding than WT protein. 
V46K, a mutant constructed to introduce another cationic side chain in the membrane 
binding site, was the least stable of the  variants expressed. 
6.4 The affinity of BtPI-PLC variants for vesicles 
     The results of FCS experiments measuring affinity of the mutants for PC/PG SUVs 
are shown in Figure 6-5 and listed in Table 6-2. As expected, all proteins have the lowest 
binding affinity for pure PG vesicles. Addition of PC led to decreases in the apparent Kd 
for all proteins, again with a minimum around XPC = 0.8. For pure PC SUVs, R71A and 
K279A have Kd values only 1.5-fold higher than WT protein. K38A and K44A had Kd 
towards PC SUVs that were 10- and 20- fold higher than WT, indicating more than 
electrostatics was altered with these alanine substitutions. At XPC > 0.5 R71A and K279A 
had apparent Kd values that approached WT protein. These two mutants recover binding 
affinity at higher XPC, presumably due to the increased contribution of specific tyrosine 
mediated cation-π interactions with PC compared to the electrostatic contribution to 
binding. This indicates their role is almost exclusively an electrostatic contribution to 
vesicle binding. The K38A mutation is much more perturbing with an approximately 10–
fold higher Kd relative to WT for SUVs containing PC. Even more detrimental is the 
K44A mutation. Whereas all the other proteins showed an increase in Kd from XPC = 0.8 
to 1.0, the K44A Kd stayed relatively constant between XPC of 0.5 to 1.0. For K44A 
binding to XPC=0.5 SUVs, the Kd was approximately 60 times higher than that of WT 
while the relative increase for K38A was approximately 20-fold. Lys44, which is an 
interfacial residue, has multiple contributions to membrane binding. Its position in the 
phospholipid headgroup region allows it to have more than just electrostatic interactions, 
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it could also participate in hydrophobic interactions with the lipid tails and to hydrogen 
bond with the phosphate group of a phospholipid. 
     
Table 6-2. Apparent Kd values for BtPI-PLC mutans.  
   Kd (mM)   
PI-PLC XPC = 0 0.2 0.5 0.8 1.0 
WT 12±1 0.31±0.01 0.016±0.001 0.0064±0.0008 0.026±0.005 
K38A 32±1 2.2±0.2 0.30±0.05 0.037±0.002 0.24±0.06 
K44A 22±4 8.8 a 1.0±0.3 0.35a 0.51±0.07 
K44A/R71A  19.7±1.3 2.22±0.33 0.626±0.078 1.05±0.34 
R71A 43±5 1.8±0.2 0.13±0.05 0.030±0.008 0.042±0.009 
K279A 
V46K 
31±7 
22±2 
0.87±0.04 
1.4±0.2 
0.092±0.011 
0.74±0.11 
0.012±0.002 
1.11±0.176 
0.034±0.008 
21±2 
 
 a Data for K44A binding at XPC=0.2 and 0.8 was interpolated from data between XPC = 
0.1 and 0.3 (14.7±2.6 and 5.43±2.13, respectively) and XPC = 0.7 and 0.9 (0.42±0.06 and 
0.33±0.03, respectively). 
 
 
Figure 6-5. Binding of PI-PLC WT and cationic amino acids mutants to SUVs. The apparent Kd 
is plotted as a function of XPC. Kd values are provided in Table 6-2. Blue line indicates the total 
phospholipid concentrations used in enzymatic assays (see Figure 6-8). 
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For each mutant protein, its apparent Kd can be compared to the apparent Kd for WT 
protein (Figure 6-6B shows such a plot for several of these mutant proteins). A value of 
ΔΔG for the loss (or gain) of binding affinity in the mutant can then be estimated from 
ΔΔG = RT ln {Kd(mutant)/Kd(WT)}. The dependence of ΔΔG on XPC is shown in Figure 
6-7A. It is apparent that the ΔΔG values for single Lys or Arg mutant proteins are 
relatively constant from XPC = 0.2 to 0.8. This is what would be expected if the mutations 
only altered electrostatic and hydrophobic interactions with phospholipids but not cation-
π contributions to membrane binding. In support of this, preliminary analysis of the MD 
simulations at XPC = 0, 0.5 and 0.8 (Hanif Khan and Nathalie Reuter, University of 
Bergen, Norway) show that both electrostatic and hydrophobic interactions of the protein 
with the membrane do not vary with the amount of PC in the membrane.  
Two other cation mutations were constructed: K44A/R71A, to see if removal of 
cationic groups was additive, and V46K, to see how introduction of another positive 
charge affect PG/PV SUV binding.  As shown in Figure 6-6A, the double mutant binds 
more poorly than K44A. The loss of binding energy for K44A/R71A Experimental is 
fairly close to the sum of the ΔΔG for each single mutation (Figure 6-7B). Values for the 
double mutant are in general slightly lower than the sum of ΔΔG for the single mutants 
with the largest difference at XPC = 0.5. Thus, it appears the electrostatic contributions are 
additive. 
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Figure 6-6. (A) Variation of apparent Kd with mole fraction PC in PG/PC SUVs for double 
mutant K44A/R71A and the single mutants K44 and R71A and for V46K which introduced a 
second positive charge in helix B. (B) Comparing the mutant Kd values to that of the WT protein.  
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Figure 6-7. (A) ΔΔG values estimated for all K!A or R!A mutations binding to PG/PC SUVs 
as a function of mole fraction PC. (B) Comparison of ΔΔG for K44A/R71A (filled triangle) to the 
sum of the individual singe mutant proteins (open triangle). 
 
 
Ile43 is the most deeply embedded side chain of helix B. Introducing a positive 
charge at residue 46 should position the side chain near the phosphate moieties of the 
phospholipids and enhance electrostatic binding. There is a very small increase in affinity 
for V46A binding to pure PG SUVs, but V46K shows a dramatic loss of affinity towards 
pure PC SUVs. Shown in Figure 6-7A is the estimated ΔΔG for this mutation, which 
shows almost a linear loss of binding energy with XPC. This strongly suggests that a 
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second Lys at residue 46 must also interfere with cation-π interactions (which according 
to MD simulations increase with increasing XPC. Exactly how this happens is unclear, 
since Trp47 was not implicated in cation-π interactions in the MD simulation. 
6.5 Enzyme activity of BtPI-PLC variants 
    Removal of cationic residues alters vesicle binding, but does this affect the activity of 
this enzyme? As shown in Figure 6-8, all single mutant proteins show only slightly 
reduced enzymatic activity relative to WT at XPC = 0.5. The lower specific activity 
towards XPC = 0 and 0.2 SUVs correlates with loss of binding affinity provided by 
altering the electrostatics. Among the single cationic residue mutations, K44A has the 
lowest specific activity at low XPC and the highest for PC-rich SUVs. Since analysis of 
vesicle binding suggests that K44A contributes more than just electrostatic interactions 
(its removal has the highest ΔΔG of any of the single cationic residue mutations), it 
would be expected to have the lowest specific activity at XPC = 0.2. Its position in helix 
B, which is anchored in the membrane, could have the methylenes contribute 
hydrophobic binding energy. Since its ΔΔG is relatively constant from XPC = 0.2 to 1.0, it 
would not appear that it has no significant effects on cation-π interactions. 
    At high XPC, all the cationic residue mutations exhibit surface dilution inhibition. . The 
weakest binding proteins (V46K, K44A/R71A, and K44A) show the highest specific 
activities, commonly seen with other BtPI-PLC mutants [8]. This likely reflects a better 
ability to dissociate from one vesicle and find another when interfacial substrate is rare. 
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Figure 6-8. Specific activity of BtPI-PLC variants towards PI/POPC SUVs with 2 mM PI and 
varying XPC: WT (solid circle), K38A (open square), K44A (open circle), R71A (solid square), 
K279A (solid diamond), V46K (inverted triangle), and K44A/R71A (solid triangle). Protein 
concentrations were adjusted to between 0.15-2 g/ml to ensure less than 20% cleavage of the PI.  
   
6.6 Conclusion 
     Polybasic motifs on amphitropic proteins surfaces are essential for binding to 
negatively charged lipid bilayers through electrostatic interactions with the negative 
charged headgroups of membrane lipids [9]. This not the case for BtPI-PLC, which 
carries an overall negative net charge and does not present any obvious cluster of basic 
amino acids at its interfacial binding site. Previous results have shown that as little as 
10% anionic phospholipid is enough to aid in driving the BtPI-PLC protein to the 
membrane [6]. Adding more anionic lipid does not help protein binding. 
    Electrostatic interactions bring the BtPI-PLC to its binding-competent orientation and 
are followed by the short-range protein lipid interactions. Among those, the cation-π 
interactions between protein tyrosines and choline groups of PC anchor the protein for 
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catalysis and increase with PC content. This particular balance of electrostatic, 
hydrophobic and cation-π interactions is optimal for BtPI-PLC to find its substrates, GPI-
anchored proteins. These occur in the outer leaflet of the eukaryotic cell plasma 
membrane, which is rich in PC and sphingomyelin. Such optimized binding behavior 
contributes to bacterial pathogenicity. Although the detailed mechanism has not been 
determined, it is thought that release of key GPI-anchored proteins by bacterial secreted 
PI-PLCs affects the innate immune response of mammalian cells and allows the bacteria 
to colonize the area. 
    For most of these Lys or Arg ! Ala mutations, the enzyme specific activity towards 
pure PI vesicles was substantially decreased with removal of one of the cationic residues, 
even if some of them were fairly distant from the active site. In terms of the binding 
profiles of mutant proteins compared with WT, Lys38 and Lys44 were found to be 
particularly important for PC binding. Especially Lys44, which is an interfacial residue, 
has high contribution for membrane binding, due to its position in the headgroup region 
where it participates in hydrophobic interaction with the lipid tails and long-lasting 
hydrogen bond with lipid phosphate group.  
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Chapter 7 
DNF2—a plant protein with homology to bacterial 
PI-PLC enzymes 
 
!!!!!!!!
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7.1 Introduction 
    A lot of legume family species are able to form symbiotic associations with nitrogen-
fixing bacteria, resulting in the development of a new compartment in the plant cell when 
the bacteria enters the plant cell by endocytosis to form the symbiosome. This specialized 
organ in the root system is also called the nodule. A model organism for studying legume 
biology, and more particularly the symbiosis between the plant and nitrogen-fixing 
bacteria, is Medicago truncatula, a plant native to Mediterranean regions (Figure 7-1). 
Figure 7-1. Images of (A) the Medicago truncatula plant and (B) the root nodules 
(symbiosomes). 
 
    The gene dnf2, from the plant Medicago truncatula (a relative of alfafa with a genome 
only half the size of the more common plant) is found in the symbiosome and is required 
for nitrogen fixation [1]. Although sequence alignment of bacterial PI-PLC and plant 
DNF2 does not show much sequence similarity, a homology model predicted with I-
tasser [2] predicted it would adopt a structure similar to a Bacillus PI-PLC (PBD: 1PTD) 
with aligned helix B and interfacial loops (Figure 7-2). Inspection of this homology 
model identified His residues aligned with those conserved in the active site of the B. 
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cereus PI-PLC. This prompts the question: is DNF2 a PI-PLC enzyme? If so, what is its 
role in symbiosome function and signaling?  
     
Figure 7-2. Homology model of DNF2. Blue: Bacillus cereus PI-PLC (PDB: 1PTG); Yellow: 
ITASSER [2] prediction for DNF2; Pink, Phyre [3] prediction for DNF2. Myo-inositol present in 
the bacterial protein is shown in stick representation. 
 
    In this study, the wild-type M. truncatula dnf2 gene was cloned into an intein-
tagged overexpression system for further expression and purification. It was found that 
DNF2 is a plant PI-PLC. Enzymatic activities using a variety of assay systems were 
measured, and mutations were designed to identify the key residues in the active site. 
Parallel to this, Onur Oztas and Prof. Dong Wang, our collaborators at the University of 
Massachusetts, Amherst, showed that DNF2 protein could cause GPI-anchored protein 
cleavage in plants. These initial results showed that DNF2 is indeed a PI-PLC with 
! 121!
specificity for PI and GPI-anchors but with low enzymatic activity compared to its 
bacterial counterparts. 
7.2 Cloning, expression and purification of DNF2 
7.2.1 Signal sequence determination for recombinant protein construct 
    The original gene plasmid (Figure 7-3) was obtained from Dr. Dong Wang, University 
of Massachusetts Amherst. The full dnf2 sequence encodes 334 amino acids. Using 
online prediction server TargetP   (http://www.cbs.dtu.dk/services/TargetP/) [4] and 
SignalP (http://www.cbs.dtu.dk/services/SignalP/) [5], the first 18 amino acids were 
determined as signal sequence and therefore not included in any subsequent recombinant 
cloning. The dnf2 gene cloned for expression contains 11 Cys residues and has a 
molecular weight of 36kDa. Similar sized bacterial PI-PLCs have very few Cys residues 
(zero in BtPI-PLC and two in L. monocytogenes PI-PLC). The theoretical pI for the 
protein, estimated with the ExPASy ProtParam tool, was 8.96.  The extinction coefficient 
(0.1%Abs) is calculated to be 1.491. The calculated instability index of DNF2 is 49.18, 
which classifies DNF2 as unstable.  
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Figure 7-3. DNF2 DNA and corresponding amino acid sequences. 
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ATGGAGAATTACCTT CTAATCGCAACTTTG ATTAGTGCAAGTCTT GTATTTGGTTGCTAT 
 M  E  N  Y  L   L  I  A  T  L   I  S  A  S  L   V  F  G  C  Y   
 
GTACTTGTTCAGATT GGGGAAACATGCTCC CGCGACGTCAATGAC TGTGGTACGGGGCTG  
 V  L  V  Q  I   G  E  T  C  S   R  D  V  N  D   C  G  T  G  L 
 
CAGTGCCTGGAATGC AACTCACAAAGCCGG TGTACACGAGTCCGA ACTTCAAGTCCTATT 
 Q  C  L  E  C   N  S  Q  S  R   C  T  R  V  R   T  S  S  P  I  
 
TCAAAAGTGATGGAG CTTCCATTTAACCAT TACTCATGGCTTACA ACTCACAACTCTTAT 
 S  K  V  M  E   L  P  F  N  H   Y  S  W  L  T   T  H  N  S  Y 
 
GCTTCGAGGGCAGCG AACTTGAGTATAGAC TCTAAAATTTCGTCG GTCATGAACCAGGAA 
 A  S  R  A  A   N  L  S  I  D   S  K  I  S  S   V  M  N  Q  E 
  
GACTCCATTACAGAT CAGCTGCGTAATGGT GTGAGAGGAATAATG TTAGATATGCATGAT 
 D  S  I  T  D   Q  L  R  N  G   V  R  G  I  M   L  D  M  H  D 
 
TACTATGGTGACATT TGGTTGTGTCGCGGA CCGTGCACAATATTT ACCGCCTTTCAACCT 
 Y  Y  G  D  I   W  L  C  R  G   P  C  T  I  F   T  A  F  Q  P 
 
GCTATTAATGTTCTG AGAGAGATCAATACA TTTCTCACACGACAC CGAACTGAGATAGTC 
 A  I  N  V  L   R  E  I  N  T   F  L  T  R  H   R  T  E  I  V 
 
ACCGTTTTCATCAAG GATCGTGTAACATCA CCAAATGGTGTGAAC AAGGTGTTTAATAAA 
 T  V  F  I  K   D  R  V  T  S   P  N  G  V  N   K  V  F  N  K 
 
GCTGGTTTGAGGAAA TTCTGGTTTCCGGTA TATAAAATGCCAAAG AATGGTAGTGATTGG 
 A  G  L  R  K   F  W  F  P  V   Y  K  M  P  K   N  G  S  D  W 
 
CTAACAGTTAAAAAA ATGTTAAGAATGAAT CATAGGTTAATTGTG TTCACTTCAAATGCA 
 L  T  V  K  K   M  L  R  M  N   H  R  L  I  V   F  T  S  N  A  
 
ACAAAAGAGGCTTCT GAACGCATTGCCTAT GAATGGAACTATGTT GTGGAAAATAAATAT 
 T  K  E  A  S   E  R  I  A  Y   E  W  N  Y  V   V  E  N  K  Y 
 
GGAAATGATGGAATG GGAAGAGATCATTGT TTACATAGAGCAGAA TCATATCCAATGAAC 
 G  N  D  G  M   G  R  D  H  C   L  H  R  A  E   S  Y  P  M  N 
 
ACAACAACAAAATCA CTAGTCCTAATGAAC TATTACAGAAATGTC CTAAATTCCAATGAA 
 T  T  T  K  S   L  V  L  M  N   Y  Y  R  N  V   L  N  S  N  E 
 
GCATGTAAGGATAAC TCATCCCCATTGATT CGAAAGATGCATACT TGCTATAAAGATGCT 
 A  C  K  D  N   S  S  P  L  I   R  K  M  H  T   C  Y  K  D  A 
 
GGTAACCGATGGCCT AACTACATTGCTGTA GACTTTTACAAGAGA GGTGATGGTGGGGGA 
 G  N  R  W  P   N  Y  I  A  V   D  F  Y  K  R   G  D  G  G  G 
 
GCTCCAGAAGCATTA GATGTTGCAAATCGA AATTTGTTTGTGTGA 
 A  P  E  A  L   D  V  A  N  R   N  L  F  V  - 
  
! 123!
7.2.2 Phosphatidylinositol-specific activity  
    The dnf2 gene without the nucleic acid sequence coding for the first 18 amino acids 
was first cloned into a pET-23b vector to be expressed with a C-terminal His-tag. An 
NdeI site was used for cloning the 5’ end of the target gene with a forward primer 5’- 
gacctggCATATGtgctatgtacttgttcagatt-3’ (NdeI site underlined). An XhoI site was used 
for cloning the 3’ end of the target gene with a reverse primer 5’-
gactccCTCGAGcacaaacaaatttcgatttgc-3’ (XhoI site underlined). The new plasmid was 
prepared and sequenced as previously described in Chapter 2, section 2.2. It was then 
transformed and overexpressed in E. coli with 100 µg/mL ampicillin. This strain of E. 
coli expressed with an empty expression vector yields no PI-PLC enzymes; cell extracts 
cannot cleave PI. When the crude cell lysate from cells expressing DNF2 was mixed with 
PI/PC vesicles, PI was cleaved to cyclic inositol phosphate (cIP). Confirmation of the 
product was provided by the 31P NMR spectrum (Figure 7-4).  
 
Figure 7-4. 31P NMR spectrum showing DNF2 activity towards PI/PC (2mM: 2mM) vesicles, in 
50mM HEPES, pH 7.5.  
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The PI-PLC activity was low, however, most of the expressed protein was found in 
inclusion bodies, likely caused by the 11 cysteine residues. This precluded purificationof 
adequate amounts of protein. DNF2 was then cloned into other vectors to try and 
optimize expression of soluble active protein. 
    N-terminal His-tagged DNF2 (pET-28a) and GST-tagged DNF2 were generated. These 
also were found in the inclusion bodies. In contrast to the C-terminal His-tagged DNF2, 
no PI cleavage was observed with these N-terminal tagged protein, even after prolonged 
incubations of crude cell extracts with PI/PC vesicles. It should be noted that 6 of the 11 
cysteines in the protein are in the N-terminal region (first 33 amino acids), and the N-
terminal His tag might have interfered with the subsequent protein folding.  
7.2.3 Intein-tagged DNF2 purification 
    According to the homology model, the first 26 amino acids are unstructured (random 
coil) and independent of the well-folded core of DNF2. Therefore, the dnf2 gene 
encoding amino acids 27-333 was cloned into a pTXB1 vector (IMPACT kit, New 
England Biolabs), which adds a C-terminal intein fusion tag (28 kDa) to DNF2 (35 kDa). 
The residue Val334 was not included, since according to the IMPACT protocol, the C-
terminal residue has an effect on on-column cleavage efficiency by DTT. A Val C-
terminus has a much lower cleavage efficiency compared to Phe333 so the codon for 
Val334 was not included in the pTXB1 vector. An NdeI site was used for cloning the 5’ 
end of the target gene with a forward primer 5’- gataatCATATGgaaacatgctcccgcgacgtc-
3’ (NdeI site underlined). A SapI site was used for cloning the 3’ end of the target gene 
with a reverse primer 5’-ggtggttGCTCTTCcgcaaaacaaatttcgatt-3’ (SapI site underlined). 
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Protein was overexpressed in BL21 (DE3) cells and eluted from a chitin column with the 
purification protocol provided by the manufacturer.  
    Cells (1 L) were inoculated at 37 °C and DNF2 expression induced by 0.1 mM IPTG 
when the OD600 reached 0.7. The induced cells were grown at 16°C for 20 h and then the 
suspension was centrifuged. The cell pellet was re-suspended in 40 mL column buffer (20 
mM Tris, pH 8.5, 0.5 M NaCl) and sonicated for 10 x 30 s on ice, and centrifuged at 
15,000 rpm for 35 min. The supernatant was loaded at 0.5 mL/min onto a 10 mL chitin 
bead column, which was pre-equilibrated with the same column buffer. After loading, the 
chitin column was washed with at least 10 volumes column buffer to thoroughly remove 
the unbound contaminants. The on-column cleavage was initiated by adding 30mL 
cleavage buffer (20 mM Tris, pH 8.5, 0.5 M NaCl, 50 mM DTT) at 2 mL/min to evenly 
distribute thiols through the column. Flow through the column was stopped and the 
column was incubated at room temperature for 20 h. The flow-through was collected and 
subjected to SDS-PAGE analysis. The SDS-PAGE result showed that the intein tag was 
not cleaved from the recombinant DNF2. The fusion protein molecular weight was 63 
kDa (Figure 7-5).  The C-terminal intein tag did not prevent most of the protein from 
ending up in inclusion bodies. Instead, the stability provided by this additional domain 
enhanced fusion protein stability and the high specificity for chitin beads made it possible 
to purify the small amount of soluble DNF2 protein. This recombinant protein was 
judged pure enough and the amount adequate for initial biochemical characterization of 
the PI-PLC enzymatic activity of this plant enzyme. Future efforts may be focused on 
obtaining tag-less DNF2.  
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Figure 7-5. SDS-PAGE of the purified DNF2-Interin fusion protein fractios. 
 
7.3 Secondary structure of the DNF2-intein fusion protein 
    Both secondary structure and thermal stability was measured from CD spectra of 
purified DNF2 fusion protein was obtained (Table 6-1). Compared to BtPI-PLC, the 
fusion protein has a slightly higher stability, Tm= 62 °C, most likely caused by the intein 
fusion tag. Secondary structure is different because of the contribution of the intein tag. 
 
Table 7-1. Analysis of secondary structure and thermal stability of DNF2-intein  compared to  
BtPI-PLC. 
 
Secondary Structure (%) Tm (oC) 
 α-helix β-sheet β-turn random coil  
DNF2-intein 18.0 33.7 16.6 31.6 62 
BtPI-PLC 22.2 30.0 17.4 29.9 56.7 
! 127!
7.4 PI-PLC activity assay  
    The specific activity of purified DNF2 fusion protein was first measured towards PI (8 
mM) solubilized in Triton X-100 (25 mM) micelles over a pH range 5.5-8.0. As shown in 
Figure 7-6A, the highest specific activity was achieved at pH 7.4, with a value of 72 nmol 
mg-1 min-1, much lower than that observed for bacterial PI-PLCs [6].  
    Many other PI-PLC enzymes  exhibit higher activity when non-substrate lipids are 
added [7,9]. For BtPI-PLC, SaPI-PLC and Listeria monocytogenes PI-PLC, cleavage of a 
monomeric substrate like dihexanoyl-PI (diC6PI) is enhanced with PC added, although 
the mechanism of activation is different for each one. As shown in Figure 7-6B, the 
cleavage of 2 mM diC6PI, which is monomeric (its critical micelle concentration is ~12-
14 mM depending on buffer), is enhanced 2- to 3-fold by the addition of either micellar 
diC7PC or long chain PC vesicles. This could be a specific activation effect of the added 
PC or it could be the result of incorporating some of the PI in aggregates - micelles or 
vesicles. To determine the cause of the interfacial activation, we checked PC activation of 
of diC8PI, which by itself has a lower CMC (~0.5 mM) than the diC6PI (12-14 mM) 
(Figure 7-6C). The addition of 2 mM diC7PC to the diC8PC micelles had no significant 
effect on diC8PI cleavage. The observed activity was comparable to what was observed 
for 2 mM diC6PI with 2 mM diC7PC added (Figure 7-6B). This result suggests the 
enhanced activity towards diC6PI with diC7PC added is the result of providing an 
interfacial substrate for the enzyme. For DNF2 acting on diC8PI with the diC7PC 
increased, there was a further enhancement in specific activity reminiscent of what was 
observed for L. monocytogenes PI-PLC, where increasing PC content in micelles or 
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vesicles reduced the formation of nonproductive aggregates of the PI-PLC with anionic 
lipids [7]. 
 
Figure 7-6: Specific activities of DNF2-intein fusion protein. (A) Specific activities toward PI (8 
mM)/Triton X-100 (12.5mM) micelles as a function of pH. (B) Specific activities of DNF2 
toward pure 2 mM diC6PI in the absence or presence of 2 mM diC7PC or 1 mM POPC vesicles. 
(C) Specific activities of DNF2 toward 2 mM diC8PI, in the absence or presence of 2 or 4 mM 
diC7PC. (D) Specific activities of DNF2 toward PI (8 mM) solubilized in Triton X-100 (12.5 
mM) or diC7PC (32 mM), in the absence or presence of 5 mM EDTA. All these assays were 
carried out in 50 mM HEPES, pH 7.4, with a protein concentration kept at 20.8 µg/mL. 
 
 
    DNF2 incubated with 10 mM EDTA for 2 h shows a small increase in activity (~1.25-
fold) compared to non-EDTA treated DNF2 in both PI/TX and PI/diC7PC assay systems 
(Figure 7-6D). The lack of a decrease in activity indicates this PI-PLC, unlike 
mammalian PLC enzymes, is not Ca2+-dependent. The very small increase probably 
! 129!
represents removal of some metal ions that tend to interact with the anionic substrate PI. 
B. thuringiensis PI-PLC activity is also not inhibited by EDTA. 
7.5 Histidine mutants 
    The homology model of DNF2 structure provides a framework for testing suspected 
active site residues. While much of DNF2 fits well on this framework, there is a switch of 
the positions of the analogs to His82 (the general acid) and Arg69 (that stabilizes the 
negative charge of the tetrahedral intermediate) [8]. The low PI-PLC activity detected for 
DNF2 has the same pH profile and some of the interfacial characteristics of both BtPI-
PLC and LmPI-PLC enzymes. As a test to see if this spatial change could account for the 
low activity of DNF2, His82 and Arg69 were switched in BtPI-PLC. The mutant enzyme 
H82R/R69H loses all its PI cleavage activity. This confirms that our DNF2 activity, 
though low, is real and not the result of switching the positions of the His and Arg. This 
result suggested that perhaps the detailed catalytic mechanism is somewhat different for 
DNF2 compared to small bacterial PI-PLC enzymes.  
    The pH profile of the DNF2 reaction suggested one or more His were involved in the 
mechanism. Also, the BLAST of DNF2 against BtPI-PLC suggested that DNF2 His77 
aligns with an active site His in the bacterial PI-PLC. Single mutations to alanine were 
made to all 8 His residues in DNF2, and specific activity toward PI/TX was measured 
with wildtype DNF2 as a control. Surprisingly, all the single His mutants retained the 
ability to cleave PI activity, although H70A, H77A and H155A only showed ~1/3 of the 
wildtype activity. Mutation of a single histidine residue does not inactivate the PI-PLC 
activity of DNF2 (as seen for the bacterial enzymes), but rather modestly reduces it. 
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However, there is another way to look at these results. DNF2 activity is measured in 
nmol min–1 mg–1; the bacterial PI-PLC activities are typically 1000-fold or more higher. 
Knocking out the active site His residues (or the Arg that stabilizes the tetrahedral 
intermediate) in the bacterial PI-PLCs reduces the PI cleavage activity by a factor of 103-
104. From the homology model, it appears that the analogues to the bacterial general acid 
and the key residue that stabilizes the tetrahedral intermediate have been swapped. This 
would certainly lead to a much lower activity where removal of key His might have only 
minor effects by comparison. 
    This leads to a very interesting conundrum: if DNF2 is a PI-PLC but with very low 
activity what is its function in cells? Is its enzymatic activity required or is there a factor 
in the symbiosome that can enhance PI or GPI-anchor cleavage? 
7.6 DNF2 PI-PLC activity is in extracts from symbiosomes? 
    To understand how DNF2 functions in the symbiosome, Onur Oztas (University of 
Massachusetts, Amherst) incubated the WT and dnf2 knockdown mutant symbiosomes 
with GPI-anchored proteins. The anti-CRD antibody can recognize the cIP epitope and 
was used for the western blot shown in Figure 7-7A. The three bands correspond to three 
epitopes of the GPI-cleaved products [10]. DNF2 is clearly required for the cleavage of 
GPI-anchored proteins in the symbiosome as monitored by the loss of bands in the extract 
from the knockdown mutant. Prior to immune detection with anti-CRD antibody, the 
SDS-PAGE was subjected to Ponseau S stain for visualization of the total protein without 
affecting the following anti-CRD detection (Figure 7-7B). Total protein and its 
distribution appeared the same for WT and dnf2 knockdown cell extracts. The results of 
the anti-CRD blot strongly suggest that DNF2 is not only a PI-PLC as shown in model 
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studies with the reocbinant enzyme, but also functions as a GPI-PLC in the plant 
symbiosome. 
Figure 7-6. GPI cleavage by DNF2 wildtype and mutant. (A) Western blot using anti-CRD for 
cIP recognizing; (B) SDS- PAGE stained with Ponseau S.  
 
7.7 Conclusion 
    In this study, we have shown that DNF2 is a novel plant PI-PLC with a key role in 
symbiosome biology. The activity for the recombinant protein in model assay systems is 
low. This might suggest this protein generated in situ is subjected to post modification in 
some way [11] to enhance activity or that it is activated by a partner protein when 
secreted into the symbiosome [12]. GPI-anchored protein cleavage also confirms that 
DNF2 is required for GPI-anchored protein cleavage in symbiosome. However, many 
questions still need to be addressed. First and foremost is to find a better expression 
system that generates DNF2 without the intein. Perhaps this can be accomplished by 
extending the C-terminus with a flexible spacer that allows DTT-induced cleavage after 
purification. If such protein can be generated, attempts to repeat kinetics with protein that 
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has no C-terminal fusion tag and perhaps even attempts at crystallization should be 
considered. 
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Chapter 8 
Future Direction 
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GPI-anchored protein cleavage, is the release of particular proteins associated with 
bacterial virulence?  
    SaPI-PLC as well as Bacillus PI-PLC target GPI-anchored proteins on the outer leaflet 
of eukaryotic cells. While µM concentrations of commercial preparations of B. cereus PI-
PLC are used to non-specifically cleave GPI-anchored proteins off the surface of 
mammalian cells, PI-PLC activity and specificity towards GPI-anchored proteins at the 
lower, physiologically relevant concentrations and shorter time scales are unclear. Shorter 
time scales are particularly relevant for escape from phagocytosis, a process in which 
bacterial PI-PLC activity has been implicated. In the phagosome, the membrane facing a 
target bacterium comes from the outer leaflet of the plasma membrane and is likely to 
display GPI-anchored proteins. PI-PLC mediated cleavage of GPI-anchored proteins will 
generate DAG, weakening this membrane. Is there also a role for cleavage of specific 
GPI-anchored proteins in hindering or arresting phagocytosis? To investigate this 
question, we will determine the identities of released proteins and whether the members 
of this population change over time.  
a. GPI-anchored protein release by SaPI-PLC  
    Neutrophils are the first host defense cells to reach infection sites. We will therefore 
use these cells as well as erythrocytes to investigate the identities of released GPI-
anchored proteins. Whole blood, obtained commercially, will be fractionated into 
individual cell types using an autoMACS Pro Separator (Miltenyi Biotec) available in the 
laboratory of Dr. Ken Williams (Boston College). Up to 20 ml of cells can be 
fractionated in this instrument and the low temperature keeps neutrophils from being 
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activated. Aliquots of each desired cell type will be assessed for purity by flow cytometry 
using the B.C. Biology Department's flow cytometry center. 
    We will start out with the more abundant erythrocytes. Initially two samples, one with 
1 nM and the other with 1 mM SaPI-PLC will be incubated at 37° C, and aliquots 
removed as a function of time, centrifuged to remove the cell pellet. The supernatant will 
be collected and precipitated with ammonium sulfate. Once this is centrifuged, the 
resulting pellet will be resuspended in phosphate buffered saline (PBS) and the 
ammonium sulfate will be removed using a desalting column. SDS-PAGE (and silver 
staining) will then be used to determine if any proteins were released into solution. The 
two extremes in enzyme concentration should give us a handle on picking the right 
concentration of SaPI-PLC so that GPI-anchored proteins are released over a 1 h time 
scale.  
    From this point, we will follow the procedure used in the Roberts lab when working 
with protein extracts from RAW cells. In brief, the proteins in the supernatant are 
unfolded in 6 M urea, reduced with DTT, heated to denature the proteins, then reacted 
with iodoacetamide to prevent disulfide formation. Protein samples are then digested with 
trypsin. After removal of the protease, the peptides need to be desalted and dried for 
analysis by LC-MS/MS analysis.  
    A parallel incubation of cells with the inactive BtPI-PLC variant H32A will serve as a 
negative control. As a positive control, at least for the erythrocytes, ghosts will be 
formed, then mixed with Triton X-100 to solubilize membrane components including the 
GPI-linkages in detergent mixed micelles. Proteins in the micelles should be more 
accessible to SaPI-PLC and thus more easily released with mM protein. This should also 
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provide us with a normalization factor for how much of a given GPI-anchored protein is 
released by the enzyme and is critical in looking for particularly susceptible proteins.  
    Since there is no data on the time course for protein release, these experiments should 
provide an interesting view into whether BtPI-PLC targets specific GPI-anchored 
proteins. An absence of specificity would indicate that DAG production is the primary 
reason that BtPI-PLC increases bacterial virulence. 
b. GPI-anchored protein release by SaPI-PLC  
    These experiments will use the same techniques described in section a above. Bacillus 
species and S. aureus occupy different environmental niches, for example S. aureus 
colonizes skin and while B. anthracis can also attack skin cells, some the most lethal 
infections result from inhalation of anthrax spores. In parallel with this environmental 
difference, PI-PLCs from these bacteria have very different lipid binding specificities 
with Bacillus PI-PLC binding specifically to PC. We therefore expect that, at the very 
least, BtPI-PLC  and SaPI-PLC will have different efficiencies for GPI-anchored protein 
cleavage. In addition, if there is cleavage specificity for GPI-anchored proteins, the 
different lipid specificities for these two related enzymes are likely to result in different 
target populations. 
    The results of these mass-spectrometry based proteomics experiments will reveal 
whether the increased virulence associated with PI-PLC expression by Gram-positive 
bacterial pathogens arises simply from the generation of DAG in host cell membranes or 
if specific cleavage of GPI-anchored proteins is also important. 
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Can we identify cation-π interactions in other amphitropic proteins? 
    BtPI-PLC has been used as a model system for characterization of cation-π interactions 
between amphitropic proteins and membranes. Prof. Nathalie Reuter and her coworkers 
have screened the OPM (Orientation of Proteins in/on membranes) database for protein 
structures that have Tyr within 10 Å of the hydrocarbon boundary. They found a lot of 
proteins fit the criteria. This might suggest that cation-π interactions are a general 
mechanism for membrane binding of amphitropic proteins. 
    To test this hypothesis, we can choose one of two of proteins that fit the search criteria. 
For example, we can choose bovine seminal plasma PCD-9 (PDB: 1H8P), which has 
phosphorylcholine co-crystallized in the structure indicating that this protein is involved 
in cation-π interactions with PC head groups. To confirm this, we can replace Tyr22 
(which is around the choline binding site) with a Y-F2. By measuring the binding affinity 
for membrane of the wild type and mutant we will be able to assess how the cation-π 
interactions affect the protein affinity for membrane. Furthermore, we can also co-
crystalize the mutant protein with phosphorylcholine to have a detailed structure analysis. 
